US20040116868A1 - Intra-pericardial drug delivery device with multiple-balloons and method for angiogenesis - Google Patents
Intra-pericardial drug delivery device with multiple-balloons and method for angiogenesis Download PDFInfo
- Publication number
- US20040116868A1 US20040116868A1 US10/678,525 US67852503A US2004116868A1 US 20040116868 A1 US20040116868 A1 US 20040116868A1 US 67852503 A US67852503 A US 67852503A US 2004116868 A1 US2004116868 A1 US 2004116868A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- communication
- shaft
- deployable
- outer shaft
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/065—Guide needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
- A61M2025/0089—Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M2025/0213—Holding devices, e.g. on the body where the catheter is attached by means specifically adapted to a part of the human body
- A61M2025/0233—Holding devices, e.g. on the body where the catheter is attached by means specifically adapted to a part of the human body specifically adapted for attaching to a body wall by means which are on both sides of the wall, e.g. for attaching to an abdominal wall
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
- A61M2210/125—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0108—Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
Definitions
- This invention relates generally to a catheter device and methods for the site-specific delivery of agents to biological spaces in medical procedures. More particularly, the invention relates to a catheter device utilizing multiple balloons and a method of site-specific delivery of agents into the pericardial space for treatment of the heart.
- Heart disease is the leading cause of death in the United States.
- One form of heart disease is caused by the formation of sclerotic plaques within blood vessels. These pathways prevent blood from flowing freely though vessels to the tissues the vessels supply.
- the most dangerous plaques are those which form in the coronary arteries, preventing the flow of oxygenated blood through the coronary arteries to the heart.
- a procedure involves methods to increase blood supply to the effected areas of the heart by clearing sclerotic plaques from the existing vessels.
- angioplasty for example, a small dilating balloon is inserted into the vessel to open the vessel to increase blood flow.
- a second procedure involves providing new pathways for blood flow. New pathways can be created by grafting in vessels (coronary artery bypass surgery) or by inducing the growth and development of new collateral vessels (therapeutic angiogenesis).
- the induction of new collateral vessels can be achieved by injections of angiogenic agents directly into the heart tissue, into vessels (coronary arteries), or into the space surrounding the heart (pericardium).
- Direct injections of agents into the heart muscle or vessels can result in tissue injury, scarring and rapid washout of the agent into the peripheral circulatory system.
- these direct injections require surgical procedures which are more costly and require a longer recovery period than catheter based procedures.
- direct injections are not preferable.
- indirect injections into the pericardium avoid these difficulties.
- the pericardium is a membrane that surrounds the heart and isolates it from the remainder of the body.
- the small space between the heart and the pericardium is the pericardial space, which is filled with pericardial fluid.
- the pericardial fluid is in constant contact with the heart muscle and coronary arteries and provides a relatively large reservoir for sustained release of drugs compared to intra-coronary methods or direct injection.
- Introduction of an agent to the pericardial space allows the agent to be contained in an area localized around the heart (epicardium and epicardial vessels).
- a lower dose of drug can be used than if given systemically due to the low volume of the pericardial fluid, 2) the low rate of turn over of the pericardial fluid allows high concentration of the agent to be maintained over a longer period, and 3) it keeps the agents out of systemic circulation where the agent may cause adverse side effects.
- the pericardial space is shallow, and thus difficult to access without puncturing (and damaging) the underlying heart tissue or coronary arteries.
- Previous attempts to access the pericardial space have utilized a syringe and needle combination, such as is used in pericardiocentesis, to directly inject agents into the pericardial space via the patient's chest.
- a syringe and needle combination such as is used in pericardiocentesis
- One of the risks inherent in such devices is the tendency for the needle to go beyond the pericardial space and to pierce the heart muscle.
- Some devices have utilized suction to draw the pericardial tissue towards the needle and thereby limit the distance the needle has to travel to deliver fluid to the pericardial space.
- Verrier discloses the use of a catheter to approach the pericardial space via the right auricle, transvenously.
- the device takes advantage of the fact that the right auricle lies tangential to and between the pericardium and epicardium such that the catheter steered into the right auricle will be positioned substantially parallel with the wall, of the pericardium.
- This approach minimizes the risk of damage to the pericardium or epicardium.
- using a catheter to pierce the pericardial wall can result in pericardial fluid flowing back into the atrium, blood flowing from the atrium into the pericardial space, and the therapeutic agent could end up being systemically administered.
- March et al. discloses delivering a gene therapy agent into the pericardial sac either surgically or by transvascular means.
- the distal end of the catheter comprises a hypotube configured as a helical coil which is to be screwed into, a heart wall to access the pericardial space.
- the device and method of March et al. is also susceptible to the backflow of pericardial fluid into the atrium and the ultimate systemic administration of the therapeutic, agent.
- the present invention provides an improved agent delivery catheter which obviates, for practical purposes, the above mentioned limitations.
- One feature of the invention is a device for accessing the pericardial space while minimizing the risk of injury to the heart during the pericardial catheterization.
- Another feature of the invention is a catheter device which minimizes leakage from the pericardium and bleeding from the atrium into the pericardial space during catheterization of a defined biological space, such as the pericardial space.
- Another feature of the invention is to provide a catheter device which minimizes longitudinal movement of the catheter from a site-specific location during the delivery or collection of agents from a defined biological space, such as the pericardial space.
- Another feature of the invention is a device having a lumen which communicates with the pericardial fluid for the site specific introduction of agents into or collection of fluid from the pericardial space.
- the catheter includes an inner shaft longitudinally movable within an outer shaft, wherein each shaft has at least one lumen within it and at least one balloon attached to it.
- the catheter includes an inner shaft longitudinally movable within an outer shaft, wherein inner shaft has at least one lumen within it and at least one balloon attached to it.
- the catheter includes an inner shaft longitudinally movable within an outer shaft, wherein each shaft has at least one lumen within it and at least two deployable wire supports attached thereto and includes at least one balloon attached therebetween.
- the catheter may include at least one lumen in each shaft, wherein the lumen may contain a guidewire, a wire support deployment mechanism, a balloon inflation source, or an agent delivery or collection source.
- the catheter may include marker bands on each shaft, such that the marker bands can be used to detect the position of the shafts relative to one another or relative to the pericardial space.
- the inner shaft of the catheter may-include a distal tip to penetrate the surface membrane of the biological space.
- the tip may further be radio-opaque so that its position can be detected during use.
- FIG. 1 is a diagrammatic representation of the heart
- FIG. 2 is a side view of an exemplary embodiment of the present invention.
- FIGS. 3 A- 3 D are a cross sectional views of the A) outer shaft; B) inner shaft; C) inner shaft within the outer shaft; and D) the present invention within a guide catheter;
- FIGS. 4 A- 4 D are side views of an exemplary embodiment of the present invention in various stages of application;
- FIGS. 5 A- 5 D are side views of the distal end of an another exemplary embodiment of the present invention in various stages of application;
- FIGS. 6 A- 6 C are side views of A) another exemplary embodiment of the present invention. B) the distal portion of the embodiment with the inner shaft deployed beyond the outer shaft C) the inner shaft non-deployed within the outer shaft;
- FIGS. 7 A- 7 C are side views of A) another exemplary embodiment of the present invention. B) the distal portion of the outer shaft of the present invention; C) the inner shaft extended beyond the outer shaft;
- FIGS. 8 A- 8 C are side views of A) another exemplary embodiment of the present invention. B) the distal portion of the outer shaft of the present invention; C) the inner shaft extended beyond the outer shaft; and
- FIGS. 9 A- 9 C are side views of A) another exemplary embodiment of the present invention. B) the distal portion of the outer shaft containing the non-deployed inner shaft; C) the distal portion of the outer shaft with the inner shaft deployed.
- FIG. 1 illustrates the heart 2 generally.
- the pericardium, or pericardial sac or membrane 4 surrounds the heart 2 (epicardium, myocardium and endocardium).
- a portion of the pericardium has been cut away to show the underlying heart, and the small space between the heart and the pericardium is the pericardial space 6 .
- the cut edge of the pericardium is 8 .
- the pericardial space 6 is one example of a defined biological space site-specifically targeted for the delivery or collection of agents by catheterization.
- one embodiment of the catheter 10 generally comprises an inner shaft 12 longitudinally movable within an outer shaft 14 along the catheter longitudinal axis 16 .
- the inner shaft 12 has at its most distal end an inner shaft distal tip 18 , and a first distal balloon 20 is located proximal to the inner shaft distal tip 18 along the catheter longitudinal axis.
- a plunger 22 At the most proximal end of the inner shaft is a plunger 22 .
- the outer shaft 14 has at its most distal end an outer shaft distal tip 23 , and a second proximal balloon 24 is located proximal to the outer shaft distal tip 23 along the catheter longitudinal axis 16 .
- the outer shaft has a handle 26 which is fixed to the outer shaft and a hub 28 which is fixed to the outer shaft, but longitudinally movable along the inner shaft.
- the ports 30 communicate with the lumens of the inner shaft 12 and outer shafts 14 allowing for access into the catheter by elements including, but not limited to guidewires, balloon inflation sources, and/or agent delivery sources.
- Lumens generally extend from the proximal ends to open distal ends of the inner or outer shaft, 12 or 14 respectively, or from a port 30 which communicates with the lumen to allow access to elements including guidewires, balloon inflation sources and/or agent delivery or collection sources.
- the outer shaft 14 has an outer shaft interior wall 40 and an outer shaft exterior wall 42 .
- the outer shaft interior wall 40 defines an outer shaft central lumen 44 .
- Outer shaft peripheral lumens 46 are formed within outer shaft 14 and are located between the outer shaft interior wall 40 and Outer shaft exterior wall 42 .
- the inner shaft 12 has an inner shaft interior wall 32 and an inner shaft exterior wall 34 .
- the inner shaft interior wall 32 defines an inner shaft central lumen 36 .
- Inner shaft peripheral lumens 38 are formed within the inner shaft 12 and are located between the inner shaft interior wall 32 and inner shaft exterior wall 34 .
- lumens may be formed in the inner shaft 12 so that the lumens are arranged axially around the catheter longitudinal axis 16 .
- the inner shaft 12 when assembled, is located within the outer shaft central lumen 44 of the catheter.
- the catheter of the present invention may be used with an outer guide catheter 50 to guide the catheter to the pericardial membrane.
- the inner shaft distal tip 18 can have orifices 48 that extend from the inner shaft central lumen 36 and/or the inner shaft peripheral lumens 38 to the inner shaft exterior wall 34 for the delivery or collection of agents to the pericardial space.
- the present invention also contemplates a method of using a catheter for the delivery or the collection of agents from a target biological space in vivo.
- the balloons act to seal off the passageway in the pericardium made by the inner shaft distal tip. This is to prevent pericardial fluid from flowing into the atrium, to prevent blood in the atrium from flowing into the pericardial space, and to insure that the therapeutic agent delivered stays within the space and is not systemically administered.
- the balloons act to stabilize the catheter within the pericardial space by being inflated against the inner and outer pericardial membrane.
- the catheter of the present invention can be used to approach the pericardial space via the right auricle, as described by Verrier. This method involves reaching the pericardial space by guiding a catheter through one of the vena cavae to the right atrium, then into the right auricle. By this approach, the catheter is substantially parallel to the wall of the pericardium, so that when the catheter is advanced through pericardium there is a low risk of piercing the underlying heart (see FIG. 1).
- the catheter of the present invention can be used to access the pericardial space via the, ventricular space. For example, the catheter can be used to access the right atrium, pierce the septum and thereafter access the left ventricle. Once in the left ventricle, the catheter is used to pierce the ventricular wall to access the pericardial space.
- the catheter 10 when inserted/introduced to the tissue preferably has the inner shaft 12 , distal balloon 20 , and inner shaft distal tip 18 retracted into the outer shaft 14 (FIG. 4A).
- the user advances the catheter toward the pericardial membrane using the handle 26 to apply forward pressure (thick arrow).
- the inner shaft 12 is removed longitudinally relative to the outer shaft 14 by applying forward pressure to the plunger 22 (thin arrow).
- the inner shaft distal tip 18 is then moved forward to pierce the pericardial membrane.
- the user advances the inner shaft until distal balloon 20 is situated within the pericardial space (thin arrow.
- the distal balloon 20 is then inflated by a balloon inflation source in communication with a port 30 and lumen in the inner shaft 12 (FIG. 4C).
- the user advances the outer shaft 14 by moving the hub 28 longitudinally forward (open arrow) relative to the inner shaft 12 until the proximal balloon 24 is firmly opposed to the outer surface of the pericardial membrane.
- the proximal balloon 24 is then inflated by a balloon inflation source in communication with a port 30 and lumen in the outer shaft 12 (FIG. 4D). Agents can then be infused or collected via the inner shaft distal tip in the pericardial space.
- the catheter can also be used to access the pericardial space by entering the right atrium, crossing the septum and entering the left ventricle.
- the catheter inner shaft distal tip 18 is moved forward to pierce the pericardial membrane and the inner shaft is advanced until distal balloon 20 is situated within the pericardial space.
- the distal balloon 20 is inflated, the outer shaft 14 is advanced until the proximal balloon 24 is firmly opposed, to the outer surface of the pericardial membrane.
- the proximal balloon 24 is then inflated and agents can then be infused or collected via the inner shaft distal tip in the pericardial space.
- catheter 110 has an inner shaft 112 longitudinally movable relative to outer shaft 114 .
- outer shaft 114 further includes a proximal pusher portion 115 which is separable from the distal end portion 116 of the outer shaft 114 to reveal inner shaft 112 .
- Outer shaft 114 has distal tip 118 , which can be a needle designed to pierce membranes and tissue, and a first balloon 120 proximal to the distal tip 118 and inner shaft 112 has distal tip 123 and second balloon 124 proximal to distal tip 123 .
- outer shaft 114 of catheter 110 has a handle 26 which is fixed to proximal pusher portion 115 of outer shaft 114 and provides longitudinal movement to pusher 115 .
- catheter 110 has the same features at its proximal end (not shown) as catheter 10 .
- Proximal pusher portion 115 has a distal end 117 that is engageable and retractable with the distal end portion 116 of outer shaft 114 by a threading or locking mechanism and in other ways known to those of skill in the art.
- proximal pusher portion 115 is engaged with distal end portion 116 of outer shaft 114 and inner shaft 112 is contained within outer shaft 114 .
- the user applies forward pressure to handle 26 to advance catheter 110 towards the pericardial membrane 4 .
- Outer shaft distal tip 118 is moved forward to pierce the pericardial membrane and outer shaft 114 is advanced forward until first balloon 120 is within the pericardial space (FIG. 5B).
- first balloon 120 is inflated by a balloon inflation source in communication with a proximal port and lumen (not shown) as in catheter 10 .
- Proximal pusher portion 115 is then retracted, revealing inner shaft 112 and second balloon 124 .
- Second balloon 124 is inflated in similar fashion to catheter 10 and agents can be infused into or collected from the pericardial space.
- the second balloon 124 is deflated and pusher 115 is advanced distally to enclose inner shaft 112 and engage with distal end portion 116 of outer shaft 114 .
- First balloon 120 is deflated and catheter 110 can then be removed from the body.
- a third embodiment of the catheter 610 generally comprises an inner shaft 612 longitudinally movable within an outer shaft 614 along the catheter longitudinal axis 616 .
- the inner shaft 612 defined by an inner shaft interior wall 661 defining inner shaft lumen 613 , and an inner shaft exterior wall 662 having at its most distal end an inner shaft distal tip 618 .
- Inflation ports 665 and 667 provide access to inner shaft lumen 613 .
- a pliable inflatable balloon 650 positioned to enclose inflation ports 665 and 667 , is attached to inner shaft exterior wall at the most proximal end of the inner shaft along the longitudinal axis of the catheter 610 .
- the outer shaft 614 defined by outer shaft interior wall 657 defining outer shaft lumen 615 , and outer shaft exterior wall 658 , has at its most distal end an outer-shaft distal tip 621 .
- the outer shaft 614 has a handle 626 which is fixed to the outer-shaft and a hub 628 which is fixed to the outer shaft, but longitudinally movable along the inner shaft.
- At the proximal end of the catheter are ports 630 .
- the ports 630 communicate with inner shaft lumen 613 and outer shaft lumen 615 allowing for access into the catheter by elements including, but not limited to guidewires, balloon inflation sources and/or agent delivery, sources.
- Lumens 613 and 615 generally extend from the proximal ends to open distal ends of the inner or outer shaft, 612 or 614 respectively, or from a port 630 which communicates with lumens 613 and 615 , respectively, to allow access to elements including guidewires, wire support deployment mechanisms, balloon inflation sources, and/or agent delivery or collection sources.
- inner shaft 612 is contained within outer shaft 614 .
- the user applies forward pressure to handle 626 to advance catheter 610 towards the pericardial membrane 604 .
- Outer shaft 614 is positioned proximal to pericardial membrane as inner shaft distal tip 618 is moved forward to pierce the pericardial membrane.
- Outer shaft 614 is then advanced forward until inner shaft distal tip 618 is within the pericardial space.
- Pliable inflatable balloon 650 is inflated by a balloon source in communication with port 630 and lumen in inner shaft 612 .
- Pliable inflatable balloon 650 serves to seal the opening created in the pericardial membrane 604 , thereby permitting isolated infusion of medicament.
- pliable inflatable balloon 650 is deflated. Inner shaft 612 retracts within outer shaft 614 . Catheter 610 can then be removed from the body.
- the catheter can also be used to access the pericardial space by entering the right atrium, crossing the septum and entering the left ventricle.
- a fourth embodiment of the catheter 710 generally comprises an inner shaft 712 longitudinally movable within an outer shaft 714 along the catheter longitudinal axis 716 .
- the inner shaft- 712 defined by an inner shaft interior wall 761 defining an inner shaft lumen 713 , and an inner shaft exterior wall 762 having at its most distal end an inner shaft distal tip 718 .
- Inflation ports- 765 and 767 provide access to inner shaft lumen 713 .
- a pliable inflatable balloon 750 positioned in fluid communication with inflation ports 765 and 767 is attached to inner shaft exterior wall 762 at the most proximal end of the inner shaft 712 along the longitudinal axis 716 of the catheter 710 .
- a first wire support 780 has a distal portion positioned proximal to inner shaft distal tip 718 , and in communication with first wire support deployment mechanism 782 through ports 784 and 785 , whereby the proximal portion flexibly attached to inner shaft exterior wall 786 .
- First wire support deployment mechanism is in communication with outer shaft handle 726 through a deployment conduit 788 .
- Deployment conduit 788 is used to slidably urge deployment mechanism 782 towards deployment ports 784 and 785 , resulting in deployment of first wire support 780 .
- the outer shaft 714 enclosing the inner shaft 712 is defined by an outer shaft interior wall 757 defining outer shaft lumen 715 , and outer shaft exterior wall 758 .
- the outer shaft 714 has at its most distal end an outer shaft distal tip 721 .
- Second wire support 790 distal portion is positioned along the catheter longitudinal axis 716 adjacent to and flexibly attached to outer shaft exterior wall 758 .
- Second wire support proximal portion communicates with inner shaft exterior wall 757 through ports 794 and 795 .
- the outer shaft has a handle 726 which is fixed to the outer shaft and a hub 728 which is fixed to the outer shaft, but longitudinally movable along the inner shaft.
- ports 730 At the proximal end of the catheter are ports 730 .
- the ports 730 communicate with the lumen 713 of the inner shaft 712 and outer shaft lumen 715 allowing for access into the catheter by elements including, but not limited to guidewires, wire support deployment mechanisms, balloon inflation sources and/or agent delivery sources.
- Lumens 713 and 715 respectively, generally extend from the proximal ends to open distal ends of the inner or outer shaft, 712 or 714 respectively, or from a port 730 which communicates with the lumens 713 and 715 , respectively, to allow access to elements including guidewires, wire support deployment mechanisms, balloon inflation sources, and/or agent delivery or collection sources.
- First wire support deployment mechanism 782 is engageable and retractable by a threading or locking mechanism and in other ways known to those of skill in the art.
- first wire support 782 is retracted and positioned along the longitudinal axis of the catheter 710 proximal to inner shaft 712 , which is contained within outer shaft 714 .
- Second wire support 790 is retracted and positioned proximal to outer shaft exterior wall 758 along the longitudinal axis of the catheter 710 .
- the user applies forward pressure to handle 726 to advance catheter 710 towards the pericardial membrane 704 .
- Inner shaft distal tip 718 is moved forward to pierce the pericardial membrane 704 .
- outer shaft distal tip 721 is positioned proximal to pericardial membrane 704 , inner shaft distal tip 418 is advanced through the pericardial membrane 704 .
- Forward advancement of inner shaft 712 slidably urges second wire support 790 through deployment port 794 and 795 , thereby deploying second wire deployment anchor 491 .
- Outer shaft 714 is advanced forward until inner shaft distal tip 718 is within the pericardial space and second wire support 790 contacts pericardial membrane 704 .
- First wire support 780 is deployed to stabilize catheter 710 .
- Pliable inflatable balloon 750 is inflated thereby isolating the pericardial space from the right atrium.
- Pliable inflatable balloon 750 is inflated by a balloon source in communication with ports 784 and 785 and lumen in inner shaft 712 , and medicament is infused into the isolated pericardial region. Upon completion of the procedure, pliable inflatable balloon 750 is deflated. Inner shaft distal tip 718 and first and second wire supports 780 and 790 respectively, are retracted. Catheter 710 can then be removed from the body.
- a fifth embodiment of the catheter 810 generally comprises an inner shaft 812 longitudinally movable within an outer shaft 814 along the catheter longitudinal axis 816 .
- the inner shaft 812 is defined by an inner shaft interior wall 861 defining an inner shaft lumen 813 , and an inner shaft exterior wall 862 having at its most distal end an inner shaft distal tip 818 .
- a first wire support 880 positioned proximal to the most distal end of the inner shaft 812 along the longitudinal axis 816 of the catheter 810 has a distal portion in communication with first wire support deployment mechanism 882 through a deployment ports 865 and 867 , and a proximal portion flexibly attached to inner shaft exterior wall 886 .
- First wire support deployment mechanism is in communication with outer shaft handle 826 through a deployment conduit 888 .
- Deployment conduit 888 is used to slidably urge deployment mechanism 882 towards deployment ports 865 and 867 resulting in first wire support 880 deployment.
- the outer shaft 814 enclosing the inner shaft 812 is defined by an outer shaft interior wall 857 and outer shaft exterior wall 858 .
- the outer shaft 814 has at its most distal end an outer shaft distal tip 821 .
- Second wire support 890 distal portion is positioned along the catheter longitudinal axis 816 adjacent to and flexibly attached to outer shaft exterior wall 858 . Second wire support proximal portion communicates with inner shaft exterior wall 857 through ports 894 and 895 .
- the outer shaft has a handle 826 which is fixed to the outer shaft and a hub 828 which is fixed to the outer shaft, but longitudinally movable along the inner shaft.
- a handle 826 which is fixed to the outer shaft
- a hub 828 which is fixed to the outer shaft, but longitudinally movable along the inner shaft.
- ports 830 At the proximal end of the catheter are ports 830 .
- the ports 830 communicate with the lumen 813 of the inner shaft 812 and outer shaft lumen 815 allowing for access into the catheter by elements including, but not limited to guidewires, wire support deployment mechanisms, and/or agent delivery sources.
- Lumens 813 and 815 generally extend from the proximal ends to open distal ends of the inner or outer shaft, 812 or 814 respectively, or from a port 830 which communicates with the lumens 813 and 815 , respectively, to allow access to elements including guidewires, wire support deployment mechanisms, and/or agent delivery or collection sources.
- First wire support deployment mechanism 882 is engageable and retractable by a threading or locking mechanism and in other ways known to those of skill in the art.
- first wire support 882 is retracted positioned along the longitudinal axis of the catheter 810 proximal to inner shaft 812 , which is contained within outer shaft 814 .
- Second wire support 890 is retracted; positioned proximal to, outer shaft exterior wall 858 along the longitudinal axis of the catheter 810 .
- the user applies forward pressure to handle 826 to advance catheter 810 towards the pericardial membrane 804 .
- Inner shaft distal tip 818 is moved forward to pierce the pericardial membrane 804 .
- inner shaft distal tip 818 is advanced through the pericardial membrane 804 .
- Forward advancement of inner shaft distal tip 818 slidably urges second wire support 890 through deployment ports 894 and 895 , structurally interacting with second wire deployment anchor 891 .
- Outer shaft 814 is advanced forward until inner shaft distal tip 818 is within the pericardial space and second wire support 890 contacts pericardial membrane 804 .
- First wire support 880 is deployed to stabilize catheter 810 , and medicament is injected into the pericardial area.
- inner shaft distal tip 818 and first and second wire supports, 880 and 890 respectively, are retracted.
- Catheter 810 can then be removed from the body.
- a sixth embodiment of the catheter 910 generally comprises an inner shaft 912 longitudinally movable within an outer shaft 914 along the catheter longitudinal axis 916 .
- the inner shaft 912 defined by an inner shaft interior wall 961 defining inner shaft lumen 913 , and an inner shaft exterior wall 962 having at its most distal end an inner shaft distal tip 918 .
- Inflation ports 965 and 967 provide access to inner shaft lumen 913 .
- a pliable inflatable balloon 950 positioned to enclose inflation ports 965 and 967 , is attached along the longitudinal axis of the catheter 910 .
- the outer shaft 914 enclosing the inner shaft is defined by an outer shaft interior wall 957 and outer shaft exterior wall 958 defining outer shaft lumen 915 .
- Outer shaft 914 has at its most distal end an outer shaft distal tip 921 , and a wire support 980 attached to outer shaft exterior wall 958 , and is functionally connected to inner shaft exterior wall 962 through deployment ports 970 and 971 respectively.
- Wire support 980 is located proximal to the outer shaft distal tip 921 along the catheter longitudinal axis 916 .
- the outer shaft 914 has a handle 926 which is fixed to the outer shaft and a hub 928 which is fixed to the outer shaft 914 , but longitudinally movable along the inner shaft.
- ports 930 At the proximal end of the catheter are ports 930 .
- the ports 930 communicate with lumens 912 and 914 respectively, thereby allowing for access into the catheter by elements including, but not limited to guidewires, wire support deployment mechanisms, balloon inflation sources and/or agent delivery sources.
- Lumens generally extend from the proximal ends to open distal ends of the inner or outer shaft, 912 or 914 respectively, or from a port 930 , to allow access to elements including guidewires, wire support deployment mechanisms, balloon inflation sources, and/or agent delivery or collection sources.
- Wire support deployment mechanism 980 has a distal end 981 that is flexibly attached to outer shaft exterior wall 958 proximal to outer shaft distal end portion 921 of outer shaft 914 by a threading or locking mechanism and in other ways known to those of skill in the art.
- wire support deployment mechanism 980 When catheter 910 is introduced into the body wire support deployment mechanism 980 is retracted, position proximal to outer shaft exterior wall 958 along the longitudinal axis of catheter 910 , and having inner shaft 912 is contained within outer shaft 914 .
- the user applies forward pressure to handle 926 to advance catheter 910 towards the pericardial membrane 904 .
- wire support 980 slidably deploys through deployment ports 970 and 971 respectively, and engages the pericardial tissue thereby providing support to catheter 910 forward advancement continuing until inner shaft distal tip 918 is within the pericardial space.
- Pliable inflatable balloon 950 is inflated by a balloon inflation source in communication with port 930 and medicament is then infused into the isolated pericardial region.
- pliable inflatable balloon 950 is deflated and inner shaft distal end 918 and wire support 980 are retracted.
- Catheter 910 can then be removed from the body.
- the catheter can be used to access the pericardial space using the Verrier technique or, alternatively, by entering the right atrium, crossing the septum and entering the left ventricle.
- the catheter inner shaft and outer shaft can be made of various materials known to those skilled in the art, including, but not limited to nylon, Pebax and polyethelene.
- the shaft materials can be selected so as to maximize column strength through the longitudinal length of the shaft. Further, the shaft materials can be braided, so as to provide sufficient column strength.
- the shaft materials can also be selected so as to allow the inner shaft to move smoothly within the outer shaft of the catheter and/or to allow the device to move smoothly within a guide catheter.
- the shaft materials can also be selected so as to maximize bonding of the shafts to the balloon materials.
- the catheter 10 / 110 can be used with a guide catheter 50 to assist in guiding the catheter to the intended target.
- a guide catheter 50 is preferably about 6-8 Fr in diameter.
- the catheter outer shaft exterior wall 42 is preferably between about 3-7 Fr. in diameter.
- the outer shaft exterior wall 42 is most preferably about 4.5 Fr.
- the outer shaft interior wall 40 is preferably between about 2-5 Fr. in diameter.
- the outer shaft interior wall 40 is most preferably about 3 Fr.
- the catheter inner shaft exterior wall 34 is preferably between about 2-5 Fr. in diameter.
- the inner shaft exterior wall 34 is most preferably about 3 Fr.
- the inner shaft interior wall 32 is preferably between about 1-4 Fr. in diameter.
- the inner shaft interior wall is most preferably about 2 Fr.
- the inner shaft distal tip 18 / 118 can be either blunt or sharp. Further, inner shaft distal tip 18 / 118 can be open or closed at the most distal end. Where the inner shaft distal tip is sharp, the tip can be a needle designed to pierce membranes and tissue.
- the needle can be made of various appropriate materials including, but not limited to, stainless steel or titanium.
- the needle can be hollow and can have orifices 48 to provide access via a lumen to the pericardial space for the delivery or collection of agents from the pericardial space.
- the distal tip can be radio-opaque to aid in the visualization during a catheterization.
- the distal and proximal balloons, 20 / 120 & 24 / 124 can be made of various materials known to those of skill in the art, including, but not limited to, latex, Kraton, polyurethane or any other biocompatible, elastomeric material, or other soft materials.
- the materials of the balloons may be selected so as to maximize pliability and/or reduce the risk of damage to tissues.
- Various balloon inflation sources known to those of skill in art can be used, such as a hand syringe in communication with lumens of the inner and/or outer shafts 12 & 14 via the appropriate proximal ports.
- the distal balloon 20 and the proximal balloon 24 when inflated, are preferably between about 3-5 mm in diameter.
- the balloons are most preferably about 3 mm in diameter.
- the balloons are preferably between about 1-2 cm in length.
- the balloons are most preferably about 1 cm long. However, the length of the balloons can be selected to be as short as possible so as to minimize tissue damage.
- the catheter 10 / 110 may have a plurality of ports 30 which communicate with the lumens 36 , 38 , 44 , and 46 within the inner shaft 12 / 112 and outer shaft 14 / 114 .
- the inner shaft central lumen 36 provides a channel for a guidewire 52
- a first inner shaft peripheral lumen 38 provides a channel for gasses or liquids to fill the distal balloon 20
- a second inner shaft peripheral lumen 38 provides a channel for the agent to be delivered to the pericardial space via the inner shaft distal tip 18 and out of the orifices 48 .
- the outer shaft central lumen 44 contains the inner shaft 12 within it
- a first outer shaft peripheral lumen 46 provides a channel for contrast media or saline to fill the proximal balloon 24 .
- the inner shaft central lumen 36 provides a channel for a guidewire 52 .
- the guidewire 52 can be retracted from the inner shaft central lumen 36 , and the agent can be delivered to the biological space via the inner shaft central lumen 36 to the inner shaft distal tip 18 / 118 .
- one or both balloons could be made of microporous materials so that agents are delivered by the balloons instead of or, in addition to the inner shaft distal tip 18 / 118 and or orifices 48 .
- the guidewire 52 may be hollow and serve as a pathway for the delivery of agents during catheter use or may remain in place in the pericardial space after removal of the catheter.
- the catheter can be visualized by thoroscopic, fluroscopic or ultrasonic visualization to determine its position in vivo, as described by Verrier in Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: A novel approach for local cardiac drug delivery. J of Am. Coll. Cardiol . (1999), herein incorporated by reference.
- imaging systems such as the Webster-Biosense NOGA system or an ultrasound system such as the Mayo-Accuson Inside-Out system may be used to determine the position of the catheter in vivo. Further, confirmation of access to the pericardial space can be confirmed by injection of contrast dye.
- inner shaft 12 / 112 and/or outer shaft 14 / 114 may include marker bands 54 which can be used to detect the position of the balloons and/or shafts relative to one another or relative to the pericardial space.
- the marker bands can be made of materials including, but not limited to platinum, gold or tantalum, which may incorporated-into the shaft walls or placed on the surface.
- a guidewire 52 can be advanced through the catheter into the pericardial space to confirm the position in the pericardial space.
- radio-opaque markers at the inner shaft distal end 18 / 118 can be used to visualize the location of the catheter using fluoroscopy during the procedure.
- the guidewires 52 can be made of materials including, but not limited to stainless steel.
- the guidewire materials can be selected such that the surface of the guidewire moves smoothly within the lumen.
- the guidewires are preferably from about 0.014-0.038 inches and most preferably from about 0.014 to about 0.018 inches in diameter.
- Agents include any one of or a combination of several agents which are gas, liquid or solid and which may be delivered or collected from the pericardial space for therapeutic or diagnostic purposes.
- Therapeutic agents include biologically active substances, or substances capable of eliciting a biological response, including, but not limited to endogenous substances (growth factors or cytokines, including, but not limited to basic fibroblast growth factor, acidic fibroblast growth factor, vascular endothelial growth factor, angiogenic factors), viral vectors, DNA capable of expressing proteins, sustained release polymers, unmodified or modified cells.
- Therapeutic agents include angiogenic agents which induce the formation of new blood vessels.
- imaging fluid may be injected into the right atrium and the pericardial space for fluid imaging of the heart and pericardial fluid may be withdrawn for diagnostic analysis.
- electrical devices may be implanted to detect electrical signals in the heart or deliver them to the heart.
- the rate of delivery of agents can be selected so as to reduce tissue damage.
- the rate of delivery of agent can depend upon at least the size and number of orifices and the pressure under which the agent is passed through the orifices.
- the rate of delivery can be controlled by osmotic pump.
- An agent delivery or collection device can be a syringe or infusion pump for slow, precise, measured delivery, in communication with a lumen via a port 30 in the inner shaft 12 / 112 .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Surgical Instruments (AREA)
Abstract
A catheter and a method for using the catheter for site specific delivery of agents to or collecting agents from biological spaces. The catheter includes an inner shaft longitudinally movable within and outer shaft, each shaft having at least one balloon and at least one lumen formed therein. The catheter prevents leaking through a membrane by sealing the tip passageway through the membrane with inflatable balloons on either side of the membrane. Further, the inflated balloons secure the position of the catheter relative to the biological membrane and biological space targeted for therapy or diagnosis.
Description
- This invention relates generally to a catheter device and methods for the site-specific delivery of agents to biological spaces in medical procedures. More particularly, the invention relates to a catheter device utilizing multiple balloons and a method of site-specific delivery of agents into the pericardial space for treatment of the heart.
- Heart disease is the leading cause of death in the United States. One form of heart disease is caused by the formation of sclerotic plaques within blood vessels. These pathways prevent blood from flowing freely though vessels to the tissues the vessels supply. The most dangerous plaques are those which form in the coronary arteries, preventing the flow of oxygenated blood through the coronary arteries to the heart.
- There are generally two surgical procedures for treating heart disease. One procedure involves methods to increase blood supply to the effected areas of the heart by clearing sclerotic plaques from the existing vessels. In angioplasty, for example, a small dilating balloon is inserted into the vessel to open the vessel to increase blood flow. A second procedure involves providing new pathways for blood flow. New pathways can be created by grafting in vessels (coronary artery bypass surgery) or by inducing the growth and development of new collateral vessels (therapeutic angiogenesis).
- The induction of new collateral vessels can be achieved by injections of angiogenic agents directly into the heart tissue, into vessels (coronary arteries), or into the space surrounding the heart (pericardium). Direct injections of agents into the heart muscle or vessels can result in tissue injury, scarring and rapid washout of the agent into the peripheral circulatory system. Furthermore, these direct injections require surgical procedures which are more costly and require a longer recovery period than catheter based procedures. Thus, direct injections, are not preferable. However, indirect injections into the pericardium avoid these difficulties.
- The pericardium is a membrane that surrounds the heart and isolates it from the remainder of the body. The small space between the heart and the pericardium is the pericardial space, which is filled with pericardial fluid. The pericardial fluid is in constant contact with the heart muscle and coronary arteries and provides a relatively large reservoir for sustained release of drugs compared to intra-coronary methods or direct injection. Introduction of an agent to the pericardial space allows the agent to be contained in an area localized around the heart (epicardium and epicardial vessels). This is beneficial in the following ways: 1) a lower dose of drug can be used than if given systemically due to the low volume of the pericardial fluid, 2) the low rate of turn over of the pericardial fluid allows high concentration of the agent to be maintained over a longer period, and 3) it keeps the agents out of systemic circulation where the agent may cause adverse side effects.
- However, the pericardial space is shallow, and thus difficult to access without puncturing (and damaging) the underlying heart tissue or coronary arteries. Previous attempts to access the pericardial space have utilized a syringe and needle combination, such as is used in pericardiocentesis, to directly inject agents into the pericardial space via the patient's chest. One of the risks inherent in such devices is the tendency for the needle to go beyond the pericardial space and to pierce the heart muscle. Some devices have utilized suction to draw the pericardial tissue towards the needle and thereby limit the distance the needle has to travel to deliver fluid to the pericardial space.
- One attempt to overcome some of the limitations inherent in procedures done through the patient's chest is a catheter based system disclosed in U.S. Pat. No. 5,269,326 to Verrier, which has been incorporated by reference in its entirety. Verrier discloses the use of a catheter to approach the pericardial space via the right auricle, transvenously. The device takes advantage of the fact that the right auricle lies tangential to and between the pericardium and epicardium such that the catheter steered into the right auricle will be positioned substantially parallel with the wall, of the pericardium. This approach minimizes the risk of damage to the pericardium or epicardium. However, using a catheter to pierce the pericardial wall can result in pericardial fluid flowing back into the atrium, blood flowing from the atrium into the pericardial space, and the therapeutic agent could end up being systemically administered.
- Another approach to introducing medicaments directly into the pericardium is disclosed in U.S. Pat. No. 5,797,870 to March et al., which has been incorporated by reference in its entirety. March et al. discloses delivering a gene therapy agent into the pericardial sac either surgically or by transvascular means. In the catheter based embodiment the distal end of the catheter comprises a hypotube configured as a helical coil which is to be screwed into, a heart wall to access the pericardial space. Like the device and method disclosed in Verrier, the device and method of March et al. is also susceptible to the backflow of pericardial fluid into the atrium and the ultimate systemic administration of the therapeutic, agent.
- What is needed, and what is provided by the present invention, is a catheter based device and method that accesses the pericardial space through the right auricle but is capable of sealing the access site so that the therapeutic agent is locally administered and flow between the auricle and the pericardial space is minimized.
- The present invention provides an improved agent delivery catheter which obviates, for practical purposes, the above mentioned limitations.
- One feature of the invention is a device for accessing the pericardial space while minimizing the risk of injury to the heart during the pericardial catheterization.
- Another feature of the invention is a catheter device which minimizes leakage from the pericardium and bleeding from the atrium into the pericardial space during catheterization of a defined biological space, such as the pericardial space.
- Another feature of the invention is to provide a catheter device which minimizes longitudinal movement of the catheter from a site-specific location during the delivery or collection of agents from a defined biological space, such as the pericardial space.
- Another feature of the invention is a device having a lumen which communicates with the pericardial fluid for the site specific introduction of agents into or collection of fluid from the pericardial space.
- In accordance with one aspect of the present invention, the catheter includes an inner shaft longitudinally movable within an outer shaft, wherein each shaft has at least one lumen within it and at least one balloon attached to it.
- In accordance with an additional embodiment of the present invention, the catheter includes an inner shaft longitudinally movable within an outer shaft, wherein inner shaft has at least one lumen within it and at least one balloon attached to it.
- In accordance with an additional embodiment of the present invention, the catheter includes an inner shaft longitudinally movable within an outer shaft, wherein each shaft has at least one lumen within it and at least two deployable wire supports attached thereto and includes at least one balloon attached therebetween.
- The catheter may include at least one lumen in each shaft, wherein the lumen may contain a guidewire, a wire support deployment mechanism, a balloon inflation source, or an agent delivery or collection source.
- The catheter may include marker bands on each shaft, such that the marker bands can be used to detect the position of the shafts relative to one another or relative to the pericardial space.
- The inner shaft of the catheter may-include a distal tip to penetrate the surface membrane of the biological space. The tip may further be radio-opaque so that its position can be detected during use.
- The above described and many other features and attendant advantages of the present invention will become apparent from a consideration of the following detailed description when considered in conjunction with the accompanying drawings.
- A detailed description of the embodiments of the invention will be made with reference to the accompanying drawings, wherein like numerals designate corresponding parts in the several figures.
- FIG. 1 is a diagrammatic representation of the heart;
- FIG. 2 is a side view of an exemplary embodiment of the present invention;
- FIGS.3A-3D are a cross sectional views of the A) outer shaft; B) inner shaft; C) inner shaft within the outer shaft; and D) the present invention within a guide catheter;
- FIGS.4A-4D are side views of an exemplary embodiment of the present invention in various stages of application;
- FIGS.5A-5D are side views of the distal end of an another exemplary embodiment of the present invention in various stages of application;
- FIGS.6A-6C are side views of A) another exemplary embodiment of the present invention; B) the distal portion of the embodiment with the inner shaft deployed beyond the outer shaft C) the inner shaft non-deployed within the outer shaft;
- FIGS.7A-7C are side views of A) another exemplary embodiment of the present invention; B) the distal portion of the outer shaft of the present invention; C) the inner shaft extended beyond the outer shaft;
- FIGS.8A-8C are side views of A) another exemplary embodiment of the present invention; B) the distal portion of the outer shaft of the present invention; C) the inner shaft extended beyond the outer shaft; and
- FIGS.9A-9C are side views of A) another exemplary embodiment of the present invention; B) the distal portion of the outer shaft containing the non-deployed inner shaft; C) the distal portion of the outer shaft with the inner shaft deployed.
- Disclosed herein is a detailed description of various illustrated embodiments of the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of illustrating the general principles of the invention. The section titles and overall organization of the present detailed description are for the purpose of convenience only and are not intended to limit the present invention.
- FIG. 1 illustrates the
heart 2 generally. The pericardium, or pericardial sac ormembrane 4, surrounds the heart 2 (epicardium, myocardium and endocardium). A portion of the pericardium has been cut away to show the underlying heart, and the small space between the heart and the pericardium is thepericardial space 6. The cut edge of the pericardium is 8. Thepericardial space 6 is one example of a defined biological space site-specifically targeted for the delivery or collection of agents by catheterization. - Detailed Description of the First Embodiment
- As illustrated in FIG. 2, one embodiment of the
catheter 10, generally comprises aninner shaft 12 longitudinally movable within anouter shaft 14 along the catheterlongitudinal axis 16. Theinner shaft 12 has at its most distal end an inner shaftdistal tip 18, and a firstdistal balloon 20 is located proximal to the inner shaftdistal tip 18 along the catheter longitudinal axis. At the most proximal end of the inner shaft is aplunger 22. Theouter shaft 14 has at its most distal end an outer shaftdistal tip 23, and a secondproximal balloon 24 is located proximal to the outer shaftdistal tip 23 along the catheterlongitudinal axis 16. The outer shaft has ahandle 26 which is fixed to the outer shaft and ahub 28 which is fixed to the outer shaft, but longitudinally movable along the inner shaft. At the proximal end of the catheter areports 30. Theports 30 communicate with the lumens of theinner shaft 12 andouter shafts 14 allowing for access into the catheter by elements including, but not limited to guidewires, balloon inflation sources, and/or agent delivery sources. Lumens generally extend from the proximal ends to open distal ends of the inner or outer shaft, 12 or 14 respectively, or from aport 30 which communicates with the lumen to allow access to elements including guidewires, balloon inflation sources and/or agent delivery or collection sources. - As illustrated in FIG. 3A, the
outer shaft 14 has an outer shaftinterior wall 40 and an outershaft exterior wall 42. The outer shaftinterior wall 40 defines an outer shaftcentral lumen 44. Outer shaftperipheral lumens 46 are formed withinouter shaft 14 and are located between the outer shaftinterior wall 40 and Outershaft exterior wall 42. As illustrated in FIG. 3B, theinner shaft 12 has an inner shaftinterior wall 32 and an innershaft exterior wall 34. The inner shaftinterior wall 32 defines an inner shaftcentral lumen 36. Inner shaftperipheral lumens 38 are formed within theinner shaft 12 and are located between the inner shaftinterior wall 32 and innershaft exterior wall 34. Alternatively, lumens may be formed in theinner shaft 12 so that the lumens are arranged axially around the catheterlongitudinal axis 16. - As illustrated in FIG. 3C, when assembled, the
inner shaft 12 is located within the outer shaftcentral lumen 44 of the catheter. The catheter of the present invention may be used with an outer guide catheter 50 to guide the catheter to the pericardial membrane. - As illustrated in FIG. 3D, the inner shaft
distal tip 18 can haveorifices 48 that extend from the inner shaftcentral lumen 36 and/or the inner shaftperipheral lumens 38 to the innershaft exterior wall 34 for the delivery or collection of agents to the pericardial space. - The present invention also contemplates a method of using a catheter for the delivery or the collection of agents from a target biological space in vivo. When used to catheterize the pericardial space the balloons act to seal off the passageway in the pericardium made by the inner shaft distal tip. This is to prevent pericardial fluid from flowing into the atrium, to prevent blood in the atrium from flowing into the pericardial space, and to insure that the therapeutic agent delivered stays within the space and is not systemically administered. Further, the balloons act to stabilize the catheter within the pericardial space by being inflated against the inner and outer pericardial membrane.
- The catheter of the present invention can be used to approach the pericardial space via the right auricle, as described by Verrier. This method involves reaching the pericardial space by guiding a catheter through one of the vena cavae to the right atrium, then into the right auricle. By this approach, the catheter is substantially parallel to the wall of the pericardium, so that when the catheter is advanced through pericardium there is a low risk of piercing the underlying heart (see FIG. 1). Alternatively, the catheter of the present invention can be used to access the pericardial space via the, ventricular space. For example, the catheter can be used to access the right atrium, pierce the septum and thereafter access the left ventricle. Once in the left ventricle, the catheter is used to pierce the ventricular wall to access the pericardial space.
- As illustrated in FIGS.4A-D, the
catheter 10 when inserted/introduced to the tissue preferably has theinner shaft 12,distal balloon 20, and inner shaftdistal tip 18 retracted into the outer shaft 14 (FIG. 4A). The user advances the catheter toward the pericardial membrane using thehandle 26 to apply forward pressure (thick arrow). When the catheter is advanced so that it is proximal to the pericardial membrane theinner shaft 12 is removed longitudinally relative to theouter shaft 14 by applying forward pressure to the plunger 22 (thin arrow). The inner shaftdistal tip 18 is then moved forward to pierce the pericardial membrane. The user advances the inner shaft untildistal balloon 20 is situated within the pericardial space (thin arrow. FIG. 4B). Thedistal balloon 20 is then inflated by a balloon inflation source in communication with aport 30 and lumen in the inner shaft 12 (FIG. 4C). The user advances theouter shaft 14 by moving thehub 28 longitudinally forward (open arrow) relative to theinner shaft 12 until theproximal balloon 24 is firmly opposed to the outer surface of the pericardial membrane. Theproximal balloon 24 is then inflated by a balloon inflation source in communication with aport 30 and lumen in the outer shaft 12 (FIG. 4D). Agents can then be infused or collected via the inner shaft distal tip in the pericardial space. - Alternatively, as discussed previously, the catheter can also be used to access the pericardial space by entering the right atrium, crossing the septum and entering the left ventricle. As discussed above, the catheter inner shaft
distal tip 18 is moved forward to pierce the pericardial membrane and the inner shaft is advanced untildistal balloon 20 is situated within the pericardial space. Thedistal balloon 20 is inflated, theouter shaft 14 is advanced until theproximal balloon 24 is firmly opposed, to the outer surface of the pericardial membrane. Theproximal balloon 24 is then inflated and agents can then be infused or collected via the inner shaft distal tip in the pericardial space. - Detailed Description of the Second Embodiment
- In an alternate embodiment illustrated in FIGS.5A-D,
catheter 110 has aninner shaft 112 longitudinally movable relative toouter shaft 114. However, in this embodimentouter shaft 114 further includes aproximal pusher portion 115 which is separable from thedistal end portion 116 of theouter shaft 114 to revealinner shaft 112.Outer shaft 114 hasdistal tip 118, which can be a needle designed to pierce membranes and tissue, and afirst balloon 120 proximal to thedistal tip 118 andinner shaft 112 hasdistal tip 123 andsecond balloon 124 proximal todistal tip 123. As withcatheter 10,outer shaft 114 ofcatheter 110 has ahandle 26 which is fixed toproximal pusher portion 115 ofouter shaft 114 and provides longitudinal movement topusher 115. In most other respects,catheter 110 has the same features at its proximal end (not shown) ascatheter 10. -
Proximal pusher portion 115 has adistal end 117 that is engageable and retractable with thedistal end portion 116 ofouter shaft 114 by a threading or locking mechanism and in other ways known to those of skill in the art. As illustrated in FIG. 5A, whencatheter 110 is introduced into the bodyproximal pusher portion 115 is engaged withdistal end portion 116 ofouter shaft 114 andinner shaft 112 is contained withinouter shaft 114. The user applies forward pressure to handle 26 to advancecatheter 110 towards thepericardial membrane 4. Outer shaftdistal tip 118 is moved forward to pierce the pericardial membrane andouter shaft 114 is advanced forward untilfirst balloon 120 is within the pericardial space (FIG. 5B). - As illustrated in FIG. 5C,
first balloon 120 is inflated by a balloon inflation source in communication with a proximal port and lumen (not shown) as incatheter 10.Proximal pusher portion 115 is then retracted, revealinginner shaft 112 andsecond balloon 124.Second balloon 124 is inflated in similar fashion tocatheter 10 and agents can be infused into or collected from the pericardial space. Upon completion of the procedure, thesecond balloon 124 is deflated andpusher 115 is advanced distally to encloseinner shaft 112 and engage withdistal end portion 116 ofouter shaft 114.First balloon 120 is deflated andcatheter 110 can then be removed from the body. - Detailed Description of the Third Embodiment
- As illustrated in FIG. 6, a third embodiment of the
catheter 610, generally comprises aninner shaft 612 longitudinally movable within anouter shaft 614 along the catheter longitudinal axis 616. Theinner shaft 612 defined by an inner shaft interior wall 661 defininginner shaft lumen 613, and an inner shaft exterior wall 662 having at its most distal end an inner shaftdistal tip 618.Inflation ports inner shaft lumen 613. A pliableinflatable balloon 650, positioned to encloseinflation ports catheter 610. Theouter shaft 614, defined by outer shaftinterior wall 657 definingouter shaft lumen 615, and outer shaftexterior wall 658, has at its most distal end an outer-shaftdistal tip 621. Theouter shaft 614 has ahandle 626 which is fixed to the outer-shaft and ahub 628 which is fixed to the outer shaft, but longitudinally movable along the inner shaft. At the proximal end of the catheter areports 630. Theports 630 communicate withinner shaft lumen 613 andouter shaft lumen 615 allowing for access into the catheter by elements including, but not limited to guidewires, balloon inflation sources and/or agent delivery, sources.Lumens port 630 which communicates withlumens - As illustrated and in accordance with the Verrier catheter insertion technique, when
catheter 610 is introduced into the body,inner shaft 612 is contained withinouter shaft 614. The user applies forward pressure to handle 626 to advancecatheter 610 towards thepericardial membrane 604.Outer shaft 614 is positioned proximal to pericardial membrane as inner shaftdistal tip 618 is moved forward to pierce the pericardial membrane.Outer shaft 614 is then advanced forward until inner shaftdistal tip 618 is within the pericardial space. Pliableinflatable balloon 650 is inflated by a balloon source in communication withport 630 and lumen ininner shaft 612. Pliableinflatable balloon 650 serves to seal the opening created in thepericardial membrane 604, thereby permitting isolated infusion of medicament. - Upon completion of the procedure, pliable
inflatable balloon 650 is deflated.Inner shaft 612 retracts withinouter shaft 614.Catheter 610 can then be removed from the body. - As discussed with respect to previous embodiments, the catheter can also be used to access the pericardial space by entering the right atrium, crossing the septum and entering the left ventricle.
- Detailed Description of the Fourth Embodiment
- As illustrated in FIG. 7, a fourth embodiment of the
catheter 710, generally comprises aninner shaft 712 longitudinally movable within anouter shaft 714 along the catheterlongitudinal axis 716. The inner shaft-712 defined by an inner shaftinterior wall 761 defining aninner shaft lumen 713, and an inner shaftexterior wall 762 having at its most distal end an inner shaftdistal tip 718. Inflation ports-765 and 767 provide access toinner shaft lumen 713. A pliableinflatable balloon 750, positioned in fluid communication withinflation ports exterior wall 762 at the most proximal end of theinner shaft 712 along thelongitudinal axis 716 of thecatheter 710. Afirst wire support 780 has a distal portion positioned proximal to inner shaftdistal tip 718, and in communication with first wiresupport deployment mechanism 782 throughports exterior wall 786. First wire support deployment mechanism is in communication with outer shaft handle 726 through adeployment conduit 788.Deployment conduit 788 is used to slidablyurge deployment mechanism 782 towardsdeployment ports first wire support 780. Theouter shaft 714 enclosing theinner shaft 712 is defined by an outer shaftinterior wall 757 definingouter shaft lumen 715, and outer shaftexterior wall 758. Theouter shaft 714 has at its most distal end an outer shaftdistal tip 721.Second wire support 790 distal portion is positioned along the catheterlongitudinal axis 716 adjacent to and flexibly attached to outer shaftexterior wall 758. Second wire support proximal portion communicates with inner shaftexterior wall 757 throughports handle 726 which is fixed to the outer shaft and ahub 728 which is fixed to the outer shaft, but longitudinally movable along the inner shaft. At the proximal end of the catheter areports 730. Theports 730, communicate with thelumen 713 of theinner shaft 712 andouter shaft lumen 715 allowing for access into the catheter by elements including, but not limited to guidewires, wire support deployment mechanisms, balloon inflation sources and/or agent delivery sources.Lumens port 730 which communicates with thelumens - First wire
support deployment mechanism 782 is engageable and retractable by a threading or locking mechanism and in other ways known to those of skill in the art. Whencatheter 710 is introduced into the bodyfirst wire support 782 is retracted and positioned along the longitudinal axis of thecatheter 710 proximal toinner shaft 712, which is contained withinouter shaft 714.Second wire support 790 is retracted and positioned proximal to outer shaftexterior wall 758 along the longitudinal axis of thecatheter 710. The user applies forward pressure to handle 726 to advancecatheter 710 towards thepericardial membrane 704. Inner shaftdistal tip 718 is moved forward to pierce thepericardial membrane 704. Once outer shaftdistal tip 721 is positioned proximal topericardial membrane 704, inner shaft distal tip 418 is advanced through thepericardial membrane 704. Forward advancement ofinner shaft 712 slidably urgessecond wire support 790 throughdeployment port Outer shaft 714 is advanced forward until inner shaftdistal tip 718 is within the pericardial space andsecond wire support 790 contactspericardial membrane 704.First wire support 780 is deployed to stabilizecatheter 710. Pliableinflatable balloon 750 is inflated thereby isolating the pericardial space from the right atrium. Pliableinflatable balloon 750 is inflated by a balloon source in communication withports inner shaft 712, and medicament is infused into the isolated pericardial region. Upon completion of the procedure, pliableinflatable balloon 750 is deflated. Inner shaftdistal tip 718 and first and second wire supports 780 and 790 respectively, are retracted.Catheter 710 can then be removed from the body. - Detailed Description of the Fifth Embodiment
- As illustrated in FIG. 8, a fifth embodiment of the
catheter 810, generally comprises aninner shaft 812 longitudinally movable within anouter shaft 814 along the catheterlongitudinal axis 816. Theinner shaft 812 is defined by an inner shaftinterior wall 861 defining aninner shaft lumen 813, and an inner shaftexterior wall 862 having at its most distal end an inner shaftdistal tip 818. Afirst wire support 880 positioned proximal to the most distal end of theinner shaft 812 along thelongitudinal axis 816 of thecatheter 810, has a distal portion in communication with first wiresupport deployment mechanism 882 through adeployment ports exterior wall 886. First wire support deployment mechanism is in communication with outer shaft handle 826 through adeployment conduit 888.Deployment conduit 888 is used to slidablyurge deployment mechanism 882 towardsdeployment ports first wire support 880 deployment. Theouter shaft 814 enclosing theinner shaft 812 is defined by an outer shaftinterior wall 857 and outer shaftexterior wall 858. Theouter shaft 814 has at its most distal end an outer shaftdistal tip 821.Second wire support 890 distal portion is positioned along the catheterlongitudinal axis 816 adjacent to and flexibly attached to outer shaftexterior wall 858. Second wire support proximal portion communicates with inner shaftexterior wall 857 throughports handle 826 which is fixed to the outer shaft and ahub 828 which is fixed to the outer shaft, but longitudinally movable along the inner shaft. At the proximal end of the catheter areports 830. Theports 830 communicate with thelumen 813 of theinner shaft 812 andouter shaft lumen 815 allowing for access into the catheter by elements including, but not limited to guidewires, wire support deployment mechanisms, and/or agent delivery sources.Lumens port 830 which communicates with thelumens - First wire
support deployment mechanism 882 is engageable and retractable by a threading or locking mechanism and in other ways known to those of skill in the art. Whencatheter 810 is introduced into the bodyfirst wire support 882 is retracted positioned along the longitudinal axis of thecatheter 810 proximal toinner shaft 812, which is contained withinouter shaft 814.Second wire support 890 is retracted; positioned proximal to, outer shaftexterior wall 858 along the longitudinal axis of thecatheter 810. The user applies forward pressure to handle 826 to advancecatheter 810 towards the pericardial membrane 804. Inner shaftdistal tip 818 is moved forward to pierce the pericardial membrane 804. Once outer shaftdistal tip 821 is positioned proximal to pericardial membrane 804, inner shaftdistal tip 818 is advanced through the pericardial membrane 804. Forward advancement of inner shaftdistal tip 818 slidably urgessecond wire support 890 throughdeployment ports wire deployment anchor 891.Outer shaft 814 is advanced forward until inner shaftdistal tip 818 is within the pericardial space andsecond wire support 890 contacts pericardial membrane 804.First wire support 880 is deployed to stabilizecatheter 810, and medicament is injected into the pericardial area. Upon completion of the procedure, inner shaftdistal tip 818 and first and second wire supports, 880 and 890 respectively, are retracted.Catheter 810 can then be removed from the body. - Detailed Description of the Sixth Embodiment
- As illustrated in FIG. 9, a sixth embodiment of the
catheter 910, generally comprises aninner shaft 912 longitudinally movable within anouter shaft 914 along the catheterlongitudinal axis 916. Theinner shaft 912 defined by an inner shaftinterior wall 961 defininginner shaft lumen 913, and an inner shaftexterior wall 962 having at its most distal end an inner shaftdistal tip 918.Inflation ports inner shaft lumen 913. A pliableinflatable balloon 950, positioned to encloseinflation ports catheter 910. Theouter shaft 914 enclosing the inner shaft is defined by an outer shaftinterior wall 957 and outer shaftexterior wall 958 definingouter shaft lumen 915.Outer shaft 914 has at its most distal end an outer shaftdistal tip 921, and awire support 980 attached to outer shaftexterior wall 958, and is functionally connected to inner shaftexterior wall 962 throughdeployment ports Wire support 980 is located proximal to the outer shaftdistal tip 921 along the catheterlongitudinal axis 916. Theouter shaft 914 has ahandle 926 which is fixed to the outer shaft and ahub 928 which is fixed to theouter shaft 914, but longitudinally movable along the inner shaft. At the proximal end of the catheter areports 930. Theports 930 communicate withlumens port 930, to allow access to elements including guidewires, wire support deployment mechanisms, balloon inflation sources, and/or agent delivery or collection sources. - Wire
support deployment mechanism 980 has adistal end 981 that is flexibly attached to outer shaftexterior wall 958 proximal to outer shaftdistal end portion 921 ofouter shaft 914 by a threading or locking mechanism and in other ways known to those of skill in the art. Whencatheter 910 is introduced into the body wiresupport deployment mechanism 980 is retracted, position proximal to outer shaftexterior wall 958 along the longitudinal axis ofcatheter 910, and havinginner shaft 912 is contained withinouter shaft 914. The user applies forward pressure to handle 926 to advancecatheter 910 towards thepericardial membrane 904. As inner shaftdistal tip 918 is moved forward,wire support 980 slidably deploys throughdeployment ports catheter 910 forward advancement continuing until inner shaftdistal tip 918 is within the pericardial space. Pliableinflatable balloon 950 is inflated by a balloon inflation source in communication withport 930 and medicament is then infused into the isolated pericardial region. Upon completion of the procedure, pliableinflatable balloon 950 is deflated and inner shaftdistal end 918 andwire support 980 are retracted.Catheter 910 can then be removed from the body. - In all of the aforementioned embodiments the catheter can be used to access the pericardial space using the Verrier technique or, alternatively, by entering the right atrium, crossing the septum and entering the left ventricle.
- Although the present invention has been described in terms of the illustrated embodiment above, numerous modifications and/or additions to the above-described illustrated embodiments would be readily apparent to one skilled in the art.
- The catheter inner shaft and outer shaft can be made of various materials known to those skilled in the art, including, but not limited to nylon, Pebax and polyethelene. The shaft materials can be selected so as to maximize column strength through the longitudinal length of the shaft. Further, the shaft materials can be braided, so as to provide sufficient column strength. The shaft materials can also be selected so as to allow the inner shaft to move smoothly within the outer shaft of the catheter and/or to allow the device to move smoothly within a guide catheter. The shaft materials can also be selected so as to maximize bonding of the shafts to the balloon materials.
- In some embodiments, the
catheter 10/110 can be used with a guide catheter 50 to assist in guiding the catheter to the intended target. Such guide catheters are preferably about 6-8 Fr in diameter. - The catheter outer
shaft exterior wall 42 is preferably between about 3-7 Fr. in diameter. The outershaft exterior wall 42 is most preferably about 4.5 Fr. The outer shaftinterior wall 40 is preferably between about 2-5 Fr. in diameter. The outer shaftinterior wall 40 is most preferably about 3 Fr. - The catheter inner
shaft exterior wall 34 is preferably between about 2-5 Fr. in diameter. The innershaft exterior wall 34 is most preferably about 3 Fr. The inner shaftinterior wall 32 is preferably between about 1-4 Fr. in diameter. The inner shaft interior wall is most preferably about 2 Fr. - The inner shaft
distal tip 18/118. can be either blunt or sharp. Further, inner shaftdistal tip 18/118 can be open or closed at the most distal end. Where the inner shaft distal tip is sharp, the tip can be a needle designed to pierce membranes and tissue. The needle can be made of various appropriate materials including, but not limited to, stainless steel or titanium. The needle can be hollow and can haveorifices 48 to provide access via a lumen to the pericardial space for the delivery or collection of agents from the pericardial space. The distal tip can be radio-opaque to aid in the visualization during a catheterization. - The distal and proximal balloons,20/120 & 24/124, can be made of various materials known to those of skill in the art, including, but not limited to, latex, Kraton, polyurethane or any other biocompatible, elastomeric material, or other soft materials. The materials of the balloons may be selected so as to maximize pliability and/or reduce the risk of damage to tissues. Various balloon inflation sources known to those of skill in art can be used, such as a hand syringe in communication with lumens of the inner and/or
outer shafts 12 & 14 via the appropriate proximal ports. - The
distal balloon 20 and theproximal balloon 24, when inflated, are preferably between about 3-5 mm in diameter. The balloons are most preferably about 3 mm in diameter. The balloons are preferably between about 1-2 cm in length. The balloons are most preferably about 1 cm long. However, the length of the balloons can be selected to be as short as possible so as to minimize tissue damage. - The
catheter 10/110 may have a plurality ofports 30 which communicate with thelumens inner shaft 12/112 andouter shaft 14/114. In one embodiment, the inner shaftcentral lumen 36 provides a channel for aguidewire 52, a first inner shaftperipheral lumen 38 provides a channel for gasses or liquids to fill thedistal balloon 20, and a second inner shaftperipheral lumen 38 provides a channel for the agent to be delivered to the pericardial space via the inner shaftdistal tip 18 and out of theorifices 48. The outer shaftcentral lumen 44 contains theinner shaft 12 within it, and a first outer shaftperipheral lumen 46 provides a channel for contrast media or saline to fill theproximal balloon 24. - In an alternate embodiment, the inner shaft
central lumen 36 provides a channel for aguidewire 52. Once thecatheter 10/110 is in place, theguidewire 52 can be retracted from the inner shaftcentral lumen 36, and the agent can be delivered to the biological space via the inner shaftcentral lumen 36 to the inner shaftdistal tip 18/118. - In another alternate embodiment, one or both balloons could be made of microporous materials so that agents are delivered by the balloons instead of or, in addition to the inner shaft
distal tip 18/118 and ororifices 48. - In another alternate embodiment, the
guidewire 52 may be hollow and serve as a pathway for the delivery of agents during catheter use or may remain in place in the pericardial space after removal of the catheter. - The catheter can be visualized by thoroscopic, fluroscopic or ultrasonic visualization to determine its position in vivo, as described by Verrier inPersistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: A novel approach for local cardiac drug delivery. J of Am. Coll. Cardiol. (1999), herein incorporated by reference. Alternatively, imaging systems such as the Webster-Biosense NOGA system or an ultrasound system such as the Mayo-Accuson Inside-Out system may be used to determine the position of the catheter in vivo. Further, confirmation of access to the pericardial space can be confirmed by injection of contrast dye.
- In some embodiments
inner shaft 12/112 and/orouter shaft 14/114 may includemarker bands 54 which can be used to detect the position of the balloons and/or shafts relative to one another or relative to the pericardial space. The marker bands can be made of materials including, but not limited to platinum, gold or tantalum, which may incorporated-into the shaft walls or placed on the surface. In some embodiments, aguidewire 52 can be advanced through the catheter into the pericardial space to confirm the position in the pericardial space. In some embodiments, radio-opaque markers at the inner shaftdistal end 18/118 can be used to visualize the location of the catheter using fluoroscopy during the procedure. - Where guidewires52 are used with the catheter, the guidewires can be made of materials including, but not limited to stainless steel. The guidewire materials can be selected such that the surface of the guidewire moves smoothly within the lumen. The guidewires are preferably from about 0.014-0.038 inches and most preferably from about 0.014 to about 0.018 inches in diameter.
- Agents include any one of or a combination of several agents which are gas, liquid or solid and which may be delivered or collected from the pericardial space for therapeutic or diagnostic purposes. Therapeutic agents include biologically active substances, or substances capable of eliciting a biological response, including, but not limited to endogenous substances (growth factors or cytokines, including, but not limited to basic fibroblast growth factor, acidic fibroblast growth factor, vascular endothelial growth factor, angiogenic factors), viral vectors, DNA capable of expressing proteins, sustained release polymers, unmodified or modified cells. Therapeutic agents include angiogenic agents which induce the formation of new blood vessels. For diagnostic purposes, imaging fluid may be injected into the right atrium and the pericardial space for fluid imaging of the heart and pericardial fluid may be withdrawn for diagnostic analysis. Further, electrical devices may be implanted to detect electrical signals in the heart or deliver them to the heart.
- The rate of delivery of agents can be selected so as to reduce tissue damage. The rate of delivery of agent can depend upon at least the size and number of orifices and the pressure under which the agent is passed through the orifices. The rate of delivery can be controlled by osmotic pump. An agent delivery or collection device can be a syringe or infusion pump for slow, precise, measured delivery, in communication with a lumen via a
port 30 in theinner shaft 12/112. - Other biological spaces which may be accessed by this catheter include but are not limited to the sub-dural and sub-arachnoid spaces of the central nervous system and the bladder. In closing, it is noted that specific illustrative embodiments of the invention have been disclosed hereinabove. However, it is to be understood that the invention is not limited to these specific embodiments. Accordingly, the invention is not limited to the precise embodiments described in detail hereinabove. With respect to the claims, it is applicant's intention that the claims not be interpreted in accordance with the sixth paragraph of 35 U.S.C. § 112 unless the term “means” is used followed by a functional statement. Further, with respect to the claims, it should be understood that any of the claims described below can be combined for the purposes of the invention.
Claims (78)
1. A catheter for delivering agents to a defined biological space in vivo comprising;
an inner catheter shaft defining at least one inner shaft lumen and having an inner shaft distal tip;
an outer catheter shaft defining at least one outer shaft lumen and having an outer shaft distal tip;
said inner catheter shaft longitudinally movable within and with respect to said outer catheter shaft; and
at least one deployable support member disposed on at least one of said inner catheter shaft and said outer catheter shaft.
2. A catheter of claim 1 , wherein said at least one deployable support member comprises at least one inflatable balloon in communication with at least one of said lumens of said inner shaft or said outer shaft.
3. A catheter of claim 2 , wherein said at least one deployable support member comprises said at least one inflatable balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen.
4. A catheter of claim 2 , wherein said at least one deployable support member comprises said at least: one inflatable balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen.
5. A catheter of claim 2 , wherein said at least one deployable support member comprises said at least one inflatable balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen, and said at least one deployable support member comprises said at least one inflatable balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen.
6. A catheter of claim 1 , wherein said at least one deployable support member comprises at least one deployable wire support in communication with at least one of said lumens of said inner shaft or said outer shaft.
7. A catheter of claim 6 , wherein said at least one deployable support member comprises said at least one deployable wire support disposed on said inner shaft and in communication with said at least one inner shaft lumen.
8. A catheter of claim 6 , wherein said at least one deployable support member comprises said at least one deployable wire support disposed on said outer shaft and in communication with said at least one outer shaft lumen.
9. A catheter of claim 6 , wherein said at least one deployable support member comprises said at least one deployable wire support disposed on said inner shaft and in communication with said at least one inner shaft lumen, and said at least one deployable support member comprises said at least one deployable wire support disposed on said outer shaft and in communication with said at least one outer shaft lumen.
10. A catheter of claim 1 , wherein said inner shaft distal tip is a needle.
11. The catheter of claim 1 , wherein said catheter disposes at least one port disposed proximate to the proximal portion of said catheter and in communication with one of said lumens in said inner shaft, and wherein said lumen is for delivery of an agent to a biological space.
12. A catheter of claim 11 , wherein the agent is a therapeutic agent.
13. A catheter of claim 11 , wherein the agent is a angiogenic agent.
14 A catheter of claim 11 , wherein said at least one port is in communication with at least one of said lumens of said inner shaft or said outer shaft and wherein at least one of said lumens is for the inflation of said inflatable balloon.
15. A catheter of claim 11 wherein said at least one port is in communication with at least one of said lumens of said inner shaft or said outer shaft and wherein at least one of said lumens is for the deployment of said deployable wire support.
16. A catheter of claim 1 , wherein said inner shaft distal tip has orifices formed therein for the delivery of an agent from aid lumen of said shaft to the biological space.
17. A catheter of claim 11 , wherein at least one port is in communication with at least one of said lumens of said inner shaft or said outer shaft and wherein at least one of said lumens are for the inflation of said inflatable balloon.
18. A catheter of claim 11 , wherein a catheter further comprises at least one inflatable sealing balloon in communication with at least one of said lumens of said inner shaft or said outer shaft thereby providing the isolated delivery of an agent to a biological space.
19. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen.
20. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen.
21. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen.
22. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen.
23. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen, and disposing said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen.
24. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, and disposing said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen.
25. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one deployable wire support in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen.
26. A catheter of claim 18 , wherein said-catheter disposes said at least one deployable support member comprising at least one-deployable wire support in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen.
27. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one deployable wire support in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen.
28. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one deployable wire support in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen.
29. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one deployable wire support in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen, and disposing said at least one deployable support member comprising at least one deployable wire support in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen.
30. A catheter of claim 18 , wherein said catheter disposes said at least one deployable support member comprising at least one deployable wire support in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, and disposing said at least, one deployable support member comprising at least one deployable wire support in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen.
31. A catheter of claim 1 , wherein said outer shaft comprises a proximal pusher portion and a distal end portion and said proximal portion is retractable from said distal end portion to reveal said inner catheter shaft.
32. A method for delivering agents to a defined biological space in vivo comprising:
providing a catheter comprising an outer catheter shaft defining at least one outer shaft lumen and having an outer shaft distal tip, and having an inner catheter shaft defining at least one inner shaft lumen and having an inner shaft distal tip, said inner catheter shaft disposed within and movable with respect to said outer catheter, and disposing at least one deployable support member disposed on at least one of said inner catheter shaft and said outer catheter shaft;
guiding said catheter to the surface of the biological space in vivo;
piercing a surface membrane of the biological space with said distal tip;
deploying at least one said deployable support member;
infusing an agent into the biological space;
retracting at least one said deployable support member; and
withdrawing said catheter from said biological space.
33. The method of claim 32 , wherein said deployable support member comprises at least one inflatable balloon in communication with at least one of said lumens of said inner shaft or said outer shaft.
34. The method of claim 33 , wherein said deployable support member comprises at least one inflatable balloon disposed on and in communication with at least one inner shaft lumen.
35. The method of claim 33 , wherein said deployable support member comprises at least one inflatable balloon disposed on and in communication with at least one outer shaft lumen.
36. The method of claim 33 , wherein said deployable support member comprises at least one inflatable balloon disposed on and in communication with at least one inner shaft lumen, and said deployable support member comprises at least one inflatable balloon disposed on and in communication with at least one outer shaft lumen.
37. The method of claim 32 , wherein said deployable support member comprises at least one deployable wire support in communication with at least one of said lumens of said inner shaft or said outer shaft.
38. The method of claim 37 , wherein said deployable support member comprises at least one deployable wire support disposed on and in communication with at least one inner shaft lumen.
39. The method of claim 37 , wherein said deployable support member comprises at least one deployable wire support disposed on and in communication with at least one outer shaft lumen.
40. The method of claim 37 , wherein said deployable support member comprises at least one deployable wire support disposed on and in communication with at least one inner shaft lumen, and at least one deployable support member comprises at least one deployable wire support disposed on and in communication with at least one, outer shaft lumen.
41. The method of claim 32 , wherein the biological space is the pericardial space.
42. The method of claim 32 , wherein the biological agent is a therapeutic agent.
43. The method of claim 32 , wherein the biological agent is an angiogenic agent.
44. The method of claim 32 , further comprising inflating at least one inflatable sealing balloon in communication with at least one of said lumens of said inner shaft or said outer shaft thereby providing the isolated delivery of an agent to a biological space.
45. The method of claim 44 , further comprising inflating a deployable support member comprising at least one inflatable balloon in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
46. The method of claim 44 , further comprising inflating a deployable support member comprising at least one inflatable balloon in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
47. The method of claim 44 , further comprising inflating a deployable support member comprising at least one inflatable balloon in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
48. The method of claim 44 , further comprising inflating a deployable support member comprising at least one inflatable balloon in communication with at least one said-outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
49. The method of claim 44 , further comprising inflating said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen, and disposing-said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
50. The method of claim 44 , further comprising inflating said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, and disposing said at least one deployable support member comprising at least one inflatable balloon in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
51. The method of claim 44 , further comprising deploying a deployable support member comprising at least one deployable wire support in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
52. The method of claim 44 , further comprising deploying a deployable support member comprising at least one deployable wire support in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
53. The method of claim 44 , further comprising deploying a deployable support member comprising at least one deployable wire support in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
54. The method of claim 44 , further comprising deploying a deployable support member comprising at least one deployable wire support in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen thereby providing a supported and isolated infusion of an agent into a biological space.
55. The method of claim 44 , further comprising deploying said at least one deployable support member comprising at least one deployable wire support in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said inner shaft and in communication with said at least one inner shaft lumen, and disposing said at least one deployable support member comprising at least one deployable wire support in communication with at least one said outer shaft and having said at least one inflatable sealing-balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
56. The method of claim 44 , further comprising deploying said at least one deployable support member comprising at least one deployable wire support in communication with at least one said inner shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, and disposing said at least-one deployable support member comprising at least one deployable wire support in communication with at least one said outer shaft and having said at least one inflatable sealing balloon disposed on said outer shaft and in communication with said at least one outer shaft lumen, thereby providing a supported and isolated infusion of an agent into a biological space.
57. The method of claim 32 , wherein said catheter further comprises a proximal pusher portion and a distal end portion and said proximal portion is retractable from said distal end portion to reveal said inner catheter shaft.
58. A catheter for delivering agents to a defined biological space in vivo comprising:
an inner catheter shaft defining at least one inner shaft lumen and having an inner shaft distal tip;
an outer catheter shaft defining at least one outer shaft lumen and having an outer shaft distal tip;
said inner catheter shaft longitudinally movable within and with respect to said outer catheter shaft; and
at least one deployable support means disposed on at least one of said inner catheter shaft and said outer catheter shaft, said deployable supporting means providing securely positioned delivery of said agents to said biological space.
59. A catheter of claim 58 , wherein said at least one deployable supporting means comprises at least one inflatable balloon in communication with at least one of said lumens of said inner shaft or said outer shaft.
60. The catheter of claim 58 , wherein said deployable support means comprises at least one inflatable balloon disposed on and in communication with at least one inner shaft lumen.
61. The catheter of claim 58 , wherein said deployable support means comprises at least one inflatable balloon disposed on and in communication with at least one outer shaft lumen.
62. The catheter of claim 58 , wherein said deployable support means comprises at least one inflatable balloon disposed on and in communication with at least one inner shaft lumen, and at least one deployable support means comprises at least one inflatable balloon disposed on and in communication with at least one outer shaft lumen.
63. The catheter of claim 58 , wherein said deployable support means comprises at least one deployable wire support in communication with at least one of said lumens of said, inner shaft or said outer shaft.
64. The catheter of claim 58 , wherein said deployable support means comprises at least one deployable wire support disposed on and in communication with at least one inner shaft lumen.
65. The catheter of claim 58 , wherein said deployable support means comprises at least one deployable wire support disposed on and in communication with at least one outer shaft lumen.
66. The catheter of claim 58 , wherein said deployable support means; comprises at least one deployable wire support disposed on and in communication with at least one inner shaft lumen, and at least one deployable support means comprises at least one deployable wire support disposed on and in communication with at least one outer shaft lumen.
67. The catheter of claim 58 , wherein the biological space is the pericardial space.
68. The catheter of claim 58 , wherein the biological agent is a therapeutic agent.
69. The catheter of claim 58 , wherein the biological agent is an angiogenic agent.
70. The catheter of claim 58 , wherein said catheter further comprises at least one sealing means in communication with at least one of said lumens of said inner shaft or said outer shaft for providing the isolated delivery of an agent to a biological space.
71. A catheter of claim 70 , wherein said at least one sealing means is disposed on said inner shaft and in communication with said at least one inner shaft lumen.
72. A catheter of claim 70 , wherein said at least one sealing means is disposed on said outer shaft and in communication with said at least one outer shaft lumen.
73. A catheter of claim 70 , wherein said catheter disposes said at least one deployable support means in communication with at least one said inner shaft and having said at least one sealing means disposed on said inner shaft and in communication with said at least one inner shaft lumen.
74. A catheter of claim 70 , wherein said catheter disposes said at least one deployable support means in communication with at least one said outer shaft and having said at least one sealing means disposed on said inner shaft and in communication with said at least one inner shaft lumen.
75. A catheter of claim 70 , wherein said catheter disposes said at least one deployable support means in communication with at least one said inner shaft and having said at least one sealing means disposed on said outer shaft and in communication with said at least one outer shaft lumen.
76. A catheter of claim 70 , wherein said catheter disposes said at least one deployable support means in communication with at least one said outer shaft and having said at least one sealing means disposed on said outer shaft and in communication with said at least one outer shaft lumen.
77. A catheter of claim 70 , wherein said catheter disposes said at least one deployable support means in communication with at least one said inner shaft and having said at least one sealing means disposed on said inner shaft and in communication with said at least one inner shaft lumen, and disposing said at least one deployable support means in communication with at least one said outer shaft and having said at least one sealing means disposed on said outer-shaft and in communication with said at least one outer shaft lumen.
78. The catheter of claim 58 , wherein said catheter further comprises a proximal pusher portion and a distal end portion and said proximal portion is retractable from said distal end portion to reveal said inner catheter shaft.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/678,525 US20040116868A1 (en) | 2000-12-19 | 2003-10-03 | Intra-pericardial drug delivery device with multiple-balloons and method for angiogenesis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/741,544 US6692458B2 (en) | 2000-12-19 | 2000-12-19 | Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis |
US10/678,525 US20040116868A1 (en) | 2000-12-19 | 2003-10-03 | Intra-pericardial drug delivery device with multiple-balloons and method for angiogenesis |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/741,544 Continuation US6692458B2 (en) | 2000-12-19 | 2000-12-19 | Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040116868A1 true US20040116868A1 (en) | 2004-06-17 |
Family
ID=24981137
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/741,544 Expired - Lifetime US6692458B2 (en) | 2000-12-19 | 2000-12-19 | Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis |
US10/678,525 Abandoned US20040116868A1 (en) | 2000-12-19 | 2003-10-03 | Intra-pericardial drug delivery device with multiple-balloons and method for angiogenesis |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/741,544 Expired - Lifetime US6692458B2 (en) | 2000-12-19 | 2000-12-19 | Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis |
Country Status (7)
Country | Link |
---|---|
US (2) | US6692458B2 (en) |
EP (2) | EP1349605B1 (en) |
JP (1) | JP4159357B2 (en) |
AT (1) | ATE328634T1 (en) |
AU (1) | AU2002231025A1 (en) |
DE (2) | DE60120480T2 (en) |
WO (1) | WO2002049702A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008143740A2 (en) * | 2007-04-06 | 2008-11-27 | Transcardiac Therapeutics, Inc. | Methods and devices for endocardiac access |
WO2009094522A1 (en) * | 2008-01-24 | 2009-07-30 | Cedars-Sinai Medical Center | Tulip-shaped balloon catheter and methods for pericardiocentesis and percutaneous pericardiotomy |
US20090287240A1 (en) * | 2008-05-16 | 2009-11-19 | Ken Yamatani | Medical instrument introduction device and method of introducing medical device |
US20100030102A1 (en) * | 2006-05-15 | 2010-02-04 | David Poston | Active Delivery and Flow Redirections: Novel Devices and Method of Delivery of Materials to Patients |
US20100331854A1 (en) * | 2008-01-07 | 2010-12-30 | Ilan Greenberg | Device and method for performing treatment in a pericardial space |
US20120078167A1 (en) * | 2010-09-27 | 2012-03-29 | Baker Andrew T | Stoma Length Indicator Assembly and Positioning System |
JP2021058642A (en) * | 2015-10-30 | 2021-04-15 | セレバスク,インコーポレイテッド | Systems and methods for treating hydrocephalus |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US6613062B1 (en) * | 1999-10-29 | 2003-09-02 | Medtronic, Inc. | Method and apparatus for providing intra-pericardial access |
US20050095268A1 (en) * | 2000-06-12 | 2005-05-05 | Acorn Cardiovascular, Inc. | Cardiac wall tension relief with cell loss management |
US7618364B2 (en) | 2000-06-12 | 2009-11-17 | Acorn Cardiovascular, Inc. | Cardiac wall tension relief device and method |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US20050267407A1 (en) * | 2002-02-01 | 2005-12-01 | Vascular Designs, Inc. | Multi-function catheter and use thereof |
JP4597526B2 (en) * | 2002-02-01 | 2010-12-15 | ロバート,ジェー. ゴールドマン | Multifunctional catheter and method of use thereof |
US8062251B2 (en) * | 2002-02-01 | 2011-11-22 | Vascular Designs, Inc. | Multi-function catheter and use thereof |
US6932804B2 (en) * | 2003-01-21 | 2005-08-23 | The Regents Of The University Of California | System and method for forming a non-ablative cardiac conduction block |
BR0311849A (en) * | 2002-05-08 | 2005-04-05 | Univ California | System for forming a conduction block in a cardiac tissue structure for treating a cardiac arrhythmia in a patient's heart, methods for treating a cardiac arrhythmia in a patient's heart, and for setting up a cardiac arrhythmia treatment system from a a plurality of cardiac delivery systems, and, system for treating a cardiac arrhythmia in a patient's heart |
US20040106896A1 (en) * | 2002-11-29 | 2004-06-03 | The Regents Of The University Of California | System and method for forming a non-ablative cardiac conduction block |
EP1503819A4 (en) * | 2002-05-08 | 2007-07-25 | Univ California | System and method for forming a non-ablative cardiac conduction block |
US7166120B2 (en) * | 2002-07-12 | 2007-01-23 | Ev3 Inc. | Catheter with occluding cuff |
US20060009827A1 (en) * | 2002-11-15 | 2006-01-12 | Kurth Paul A | Method and apparatus for anchoring of pacing leads |
US7883500B2 (en) * | 2003-03-26 | 2011-02-08 | G&L Consulting, Llc | Method and system to treat and prevent myocardial infarct expansion |
US7204824B2 (en) * | 2003-07-29 | 2007-04-17 | Harry Moulis | Medical liquid delivery device |
US20070198078A1 (en) | 2003-09-03 | 2007-08-23 | Bolton Medical, Inc. | Delivery system and method for self-centering a Proximal end of a stent graft |
US11259945B2 (en) | 2003-09-03 | 2022-03-01 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US9198786B2 (en) | 2003-09-03 | 2015-12-01 | Bolton Medical, Inc. | Lumen repair device with capture structure |
US11596537B2 (en) | 2003-09-03 | 2023-03-07 | Bolton Medical, Inc. | Delivery system and method for self-centering a proximal end of a stent graft |
US8500792B2 (en) * | 2003-09-03 | 2013-08-06 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US7763063B2 (en) | 2003-09-03 | 2010-07-27 | Bolton Medical, Inc. | Self-aligning stent graft delivery system, kit, and method |
US8292943B2 (en) | 2003-09-03 | 2012-10-23 | Bolton Medical, Inc. | Stent graft with longitudinal support member |
US20080264102A1 (en) | 2004-02-23 | 2008-10-30 | Bolton Medical, Inc. | Sheath Capture Device for Stent Graft Delivery System and Method for Operating Same |
US7758541B2 (en) * | 2004-08-17 | 2010-07-20 | Boston Scientific Scimed, Inc. | Targeted drug delivery device and method |
US7618410B2 (en) * | 2004-10-05 | 2009-11-17 | Cardia Access, Inc. | Devices and methods for access through a tissue wall |
US20060129126A1 (en) * | 2004-11-19 | 2006-06-15 | Kaplitt Michael G | Infusion device and method for infusing material into the brain of a patient |
US7226440B2 (en) * | 2005-01-31 | 2007-06-05 | G & L Consulting, Llc | Method and device for accessing a pericardial space |
US7993362B2 (en) * | 2005-02-16 | 2011-08-09 | Boston Scientific Scimed, Inc. | Filter with positioning and retrieval devices and methods |
US20060189840A1 (en) * | 2005-02-18 | 2006-08-24 | Acorn Cardiovascular, Inc. | Transmyocardial delivery of cardiac wall tension relief |
US7879050B2 (en) * | 2005-03-23 | 2011-02-01 | Wilk Peter J | Trans-vascular surgical method and associated device |
US20060229573A1 (en) * | 2005-04-08 | 2006-10-12 | Mckinley Medical L.L.L.P. | Adjustable infusion catheter |
US7963941B2 (en) * | 2005-04-12 | 2011-06-21 | Wilk Peter J | Intra-abdominal medical method and associated device |
US20060247672A1 (en) * | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for pericardial access |
US9023075B2 (en) * | 2006-06-30 | 2015-05-05 | Cvdevices, Llc | Devices, systems, and methods for lead delivery |
US20100069849A1 (en) * | 2006-06-30 | 2010-03-18 | Kassab Ghassan S | Percutaneous intravascular access to cardiac tissue |
WO2008134245A1 (en) * | 2007-04-27 | 2008-11-06 | Cvdevices, Llc | Devices, systems, and methods for promotion of infarct healing and reinforcement of border zone |
US8617205B2 (en) | 2007-02-01 | 2013-12-31 | Cook Medical Technologies Llc | Closure device |
WO2008094706A2 (en) * | 2007-02-01 | 2008-08-07 | Cook Incorporated | Closure device and method of closing a bodily opening |
EP2131908A2 (en) * | 2007-02-28 | 2009-12-16 | Medtronic, Inc. | Implantable medical device system with fixation member |
AU2008349770B2 (en) * | 2007-04-27 | 2014-10-16 | Cvdevices, Llc | Steering engagement catheter devices, systems and methods |
JP5174891B2 (en) * | 2007-04-27 | 2013-04-03 | シーヴィ デヴァイシズ,エルエルシー | Devices, systems, and methods for accessing the epicardial surface of the heart |
US8540674B2 (en) | 2007-04-27 | 2013-09-24 | Cvdevices, Llc | Devices, systems, and methods for transeptal atrial puncture using an engagement catheter platform |
US9050064B2 (en) * | 2007-04-27 | 2015-06-09 | Cvdevices, Llc | Systems for engaging a bodily tissue and methods of using the same |
AU2008246083B2 (en) * | 2007-04-27 | 2013-08-22 | Cvdevices, Llc | Devices, systems, and methods for accessing the epicardial surface of the heart |
US8718746B2 (en) * | 2007-06-21 | 2014-05-06 | Mardil, Inc. | Pericardial space imaging for cardiac support device implantation |
US20090036965A1 (en) * | 2007-07-30 | 2009-02-05 | Robert Glenmore Walsh | Conjunctive stent therapy |
US20090036875A1 (en) * | 2007-07-30 | 2009-02-05 | Robert Glenmore Walsh | Cardiac tissue therapy |
US8292907B2 (en) | 2007-08-31 | 2012-10-23 | Cook Medical Technologies Llc | Balloon assisted occlusion device |
EP3636220A3 (en) | 2008-06-30 | 2020-07-22 | Bolton Medical Inc. | Abdominal aortic aneurysms systems |
US8162879B2 (en) | 2008-09-22 | 2012-04-24 | Tyco Healthcare Group Lp | Double balloon catheter and methods for homogeneous drug delivery using the same |
JP5687216B2 (en) | 2009-03-13 | 2015-03-18 | ボルトン メディカル インコーポレイテッド | System and method for deploying an endoluminal prosthesis at a surgical site |
US20110022026A1 (en) | 2009-07-21 | 2011-01-27 | Lake Region Manufacturing, Inc. d/b/a Lake Region Medical. Inc. | Methods and Devices for Delivering Drugs Using Drug-Delivery or Drug-Coated Guidewires |
US10512761B2 (en) | 2009-12-02 | 2019-12-24 | Renovorx, Inc. | Methods for delivery of therapeutic materials to treat pancreatic cancer |
US9457171B2 (en) | 2009-12-02 | 2016-10-04 | Renovorx, Inc. | Devices, methods and kits for delivery of therapeutic materials to a target artery |
ES2828722T3 (en) | 2009-12-02 | 2021-05-27 | Renovorx Inc | Devices and kits for delivery of therapeutic materials to a pancreas |
US20110224720A1 (en) * | 2010-03-11 | 2011-09-15 | Cvdevices, Llc | Devices, systems, and methods for closing a hole in cardiac tissue |
EP2627265B8 (en) | 2010-10-15 | 2019-02-20 | Cook Medical Technologies LLC | Occlusion device for blocking fluid flow through bodily passages |
EP2811939B8 (en) | 2012-02-10 | 2017-11-15 | CVDevices, LLC | Products made of biological tissues for stents and methods of manufacturing |
EP2846743B1 (en) | 2012-04-12 | 2016-12-14 | Bolton Medical Inc. | Vascular prosthetic delivery device |
US8834506B2 (en) | 2012-09-24 | 2014-09-16 | Fawaz ALHUMAID | Method for puncturing the pericardial membrane by synchronizing needle advancement with cardiac muscle motion |
AU2014214700B2 (en) | 2013-02-11 | 2018-01-18 | Cook Medical Technologies Llc | Expandable support frame and medical device |
US9439751B2 (en) | 2013-03-15 | 2016-09-13 | Bolton Medical, Inc. | Hemostasis valve and delivery systems |
WO2014197362A1 (en) | 2013-06-03 | 2014-12-11 | Ramtin Agah | Devices, methods and kits for delivery of therapeutic materials to a pancreas |
US9326793B2 (en) | 2013-07-16 | 2016-05-03 | Fawaz ALHUMAID | Needle for physically separating and penetrating the pericardium |
EP3206741A4 (en) * | 2014-10-13 | 2018-05-02 | Emory University | Delivery devices, systems and methods for delivering therapeutic materials |
US10864354B2 (en) * | 2016-11-17 | 2020-12-15 | Boston Scientific Scimed Inc | Hydraulic auto crossing balloon/catheter |
US10695543B2 (en) | 2017-05-18 | 2020-06-30 | Renovorx, Inc. | Methods for treating cancerous tumors |
US11052224B2 (en) | 2017-05-18 | 2021-07-06 | Renovorx, Inc. | Methods for treating cancerous tumors |
CN109513099B (en) * | 2018-10-23 | 2021-08-13 | 季晓玲 | Gynecological nursing is with device of dosing |
RU2732282C1 (en) * | 2020-03-26 | 2020-09-15 | Общество с ограниченной ответственностью НПП "Спецкабель" | Symmetrical high-frequency sealed cable with low fire hazard |
WO2023235316A1 (en) * | 2022-05-31 | 2023-12-07 | Edwards Lifesciences Corporation | Soft tissue access support devices and methods |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5069662A (en) * | 1988-10-21 | 1991-12-03 | Delcath Systems, Inc. | Cancer treatment |
US5075108A (en) * | 1986-01-03 | 1991-12-24 | Consolidated Pharmaceuticals, Limited | Melphalan derivatives |
US5304120A (en) * | 1992-07-01 | 1994-04-19 | Btx Inc. | Electroporation method and apparatus for insertion of drugs and genes into endothelial cells |
US5403834A (en) * | 1992-12-07 | 1995-04-04 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US5405919A (en) * | 1992-08-24 | 1995-04-11 | The United States Of America As Represented By The Secretary Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders |
US6071263A (en) * | 1992-03-02 | 2000-06-06 | Kirkman; Thomas R. | Apparatus and method for retaining a catheter in a blood vessel in a fixed position |
US6508777B1 (en) * | 1998-05-08 | 2003-01-21 | Cardeon Corporation | Circulatory support system and method of use for isolated segmental perfusion |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4531936A (en) | 1981-01-29 | 1985-07-30 | Gordon Robert T | Device and method for the selective delivery of drugs to the myocardium |
US4824436A (en) | 1985-04-09 | 1989-04-25 | Harvey Wolinsky | Method for the prevention of restenosis |
IT8629545V0 (en) * | 1986-06-12 | 1986-06-12 | Fina Ernesto | SET BALLOON URETERAL CATHETER BALLOON FOR EXTRACTION OF URETERAL STONES |
US5087244A (en) | 1989-01-31 | 1992-02-11 | C. R. Bard, Inc. | Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen |
US5698531A (en) | 1989-03-31 | 1997-12-16 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
HU212760B (en) | 1989-06-20 | 1997-02-28 | Denes | Method and device for the apportion of chemical materials into the vein wall |
US4968306A (en) | 1989-07-07 | 1990-11-06 | Advanced Cardiovascular Systems, Inc. | Intravascular catheter having an adjustable length infusion section to delivery therapeutic fluid |
US5071428A (en) | 1989-09-08 | 1991-12-10 | Ventritex, Inc. | Method and apparatus for providing intrapericardial access and inserting intrapericardial electrodes |
US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
US5674192A (en) | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5192290A (en) * | 1990-08-29 | 1993-03-09 | Applied Medical Resources, Inc. | Embolectomy catheter |
US5527292A (en) | 1990-10-29 | 1996-06-18 | Scimed Life Systems, Inc. | Intravascular device for coronary heart treatment |
US5176643A (en) | 1991-04-29 | 1993-01-05 | George C. Kramer | System and method for rapid vascular drug delivery |
US5167628A (en) | 1991-05-02 | 1992-12-01 | Boyles Paul W | Aortic balloon catheter assembly for indirect infusion of the coronary arteries |
US5458568A (en) | 1991-05-24 | 1995-10-17 | Cortrak Medical, Inc. | Porous balloon for selective dilatation and drug delivery |
CA2074304C (en) | 1991-08-02 | 1996-11-26 | Cyril J. Schweich, Jr. | Drug delivery catheter |
US5269326A (en) * | 1991-10-24 | 1993-12-14 | Georgetown University | Method for transvenously accessing the pericardial space via the right auricle for medical procedures |
US5306250A (en) | 1992-04-02 | 1994-04-26 | Indiana University Foundation | Method and apparatus for intravascular drug delivery |
US5254089A (en) | 1992-04-02 | 1993-10-19 | Boston Scientific Corp. | Medication dispensing balloon catheter |
US5368566A (en) | 1992-04-29 | 1994-11-29 | Cardiovascular Dynamics, Inc. | Delivery and temporary stent catheter having a reinforced perfusion lumen |
US5569184A (en) | 1992-04-29 | 1996-10-29 | Cardiovascular Dynamics, Inc. | Delivery and balloon dilatation catheter and method of using |
US5458573A (en) | 1992-05-01 | 1995-10-17 | American Biomed, Inc. | Everting toposcopic dilation catheter |
US5538504A (en) | 1992-07-14 | 1996-07-23 | Scimed Life Systems, Inc. | Intra-extravascular drug delivery catheter and method |
US5336178A (en) | 1992-11-02 | 1994-08-09 | Localmed, Inc. | Intravascular catheter with infusion array |
US5279565A (en) | 1993-02-03 | 1994-01-18 | Localmed, Inc. | Intravascular treatment apparatus and method |
US5538512A (en) | 1993-02-25 | 1996-07-23 | Zenzon; Wendy J. | Lubricious flow directed catheter |
US5523092A (en) | 1993-04-14 | 1996-06-04 | Emory University | Device for local drug delivery and methods for using the same |
US5716410A (en) | 1993-04-30 | 1998-02-10 | Scimed Life Systems, Inc. | Temporary stent and method of use |
JPH0751379A (en) | 1993-06-24 | 1995-02-28 | Cardiovascular Dynamics Inc | Injection catheter, intravascular site treating method, and production of catheter |
US5397307A (en) | 1993-12-07 | 1995-03-14 | Schneider (Usa) Inc. | Drug delivery PTCA catheter and method for drug delivery |
US5599306A (en) | 1994-04-01 | 1997-02-04 | Localmed, Inc. | Method and apparatus for providing external perfusion lumens on balloon catheters |
US5464395A (en) | 1994-04-05 | 1995-11-07 | Faxon; David P. | Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway |
US5415636A (en) * | 1994-04-13 | 1995-05-16 | Schneider (Usa) Inc | Dilation-drug delivery catheter |
US5836905A (en) | 1994-06-20 | 1998-11-17 | Lemelson; Jerome H. | Apparatus and methods for gene therapy |
US5681278A (en) | 1994-06-23 | 1997-10-28 | Cormedics Corp. | Coronary vasculature treatment method |
US5514092A (en) | 1994-08-08 | 1996-05-07 | Schneider (Usa) Inc. | Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration |
US5652225A (en) | 1994-10-04 | 1997-07-29 | St. Elizabeth's Medical Center Of Boston, Inc. | Methods and products for nucleic acid delivery |
US5554114A (en) | 1994-10-20 | 1996-09-10 | Micro Therapeutics, Inc. | Infusion device with preformed shape |
US5817144A (en) | 1994-10-25 | 1998-10-06 | Latis, Inc. | Method for contemporaneous application OF laser energy and localized pharmacologic therapy |
US5626562A (en) | 1994-11-28 | 1997-05-06 | Devices For Vascular Intervention | Drug delivery catheter |
US5571168A (en) * | 1995-04-05 | 1996-11-05 | Scimed Lifesystems Inc | Pull back stent delivery system |
US5797870A (en) | 1995-06-07 | 1998-08-25 | Indiana University Foundation | Pericardial delivery of therapeutic and diagnostic agents |
US5827216A (en) | 1995-06-07 | 1998-10-27 | Cormedics Corp. | Method and apparatus for accessing the pericardial space |
US5693029A (en) | 1995-07-10 | 1997-12-02 | World Medical Manufacturing Corporation | Pro-cell intra-cavity therapeutic agent delivery device |
US5925016A (en) | 1995-09-27 | 1999-07-20 | Xrt Corp. | Systems and methods for drug delivery including treating thrombosis by driving a drug or lytic agent through the thrombus by pressure |
WO1997016169A1 (en) | 1995-11-01 | 1997-05-09 | Chiron Corporation | Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space |
US5882334A (en) | 1995-12-04 | 1999-03-16 | Target Therapeutics, Inc. | Balloon/delivery catheter assembly with adjustable balloon positioning |
US5833658A (en) | 1996-04-29 | 1998-11-10 | Levy; Robert J. | Catheters for the delivery of solutions and suspensions |
US6447539B1 (en) * | 1996-09-16 | 2002-09-10 | Transvascular, Inc. | Method and apparatus for treating ischemic heart disease by providing transvenous myocardial perfusion |
US6117153A (en) * | 1996-10-03 | 2000-09-12 | Interventional Technologies, Inc. | Neovascularization catheter |
US5931810A (en) | 1996-12-05 | 1999-08-03 | Comedicus Incorporated | Method for accessing the pericardial space |
US5873865A (en) | 1997-02-07 | 1999-02-23 | Eclipse Surgical Technologies, Inc. | Spiral catheter with multiple guide holes |
US5876373A (en) | 1997-04-04 | 1999-03-02 | Eclipse Surgical Technologies, Inc. | Steerable catheter |
US6129704A (en) | 1997-06-12 | 2000-10-10 | Schneider (Usa) Inc. | Perfusion balloon catheter having a magnetically driven impeller |
EP0893138B1 (en) | 1997-06-23 | 2004-05-26 | Schneider (Europe) GmbH | Catheter assembly |
US5972013A (en) | 1997-09-19 | 1999-10-26 | Comedicus Incorporated | Direct pericardial access device with deflecting mechanism and method |
US6592552B1 (en) | 1997-09-19 | 2003-07-15 | Cecil C. Schmidt | Direct pericardial access device and method |
US6458092B1 (en) * | 1998-09-30 | 2002-10-01 | C. R. Bard, Inc. | Vascular inducing implants |
US6193763B1 (en) | 1998-12-17 | 2001-02-27 | Robert A. Mackin | Apparatus and method for contemporaneous treatment and fluoroscopic mapping of body tissue |
-
2000
- 2000-12-19 US US09/741,544 patent/US6692458B2/en not_active Expired - Lifetime
-
2001
- 2001-12-13 DE DE60120480T patent/DE60120480T2/en not_active Expired - Lifetime
- 2001-12-13 AU AU2002231025A patent/AU2002231025A1/en not_active Abandoned
- 2001-12-13 AT AT01991287T patent/ATE328634T1/en not_active IP Right Cessation
- 2001-12-13 EP EP01991287A patent/EP1349605B1/en not_active Expired - Lifetime
- 2001-12-13 WO PCT/US2001/049026 patent/WO2002049702A2/en active IP Right Grant
- 2001-12-13 JP JP2002551039A patent/JP4159357B2/en not_active Expired - Fee Related
- 2001-12-13 EP EP06076003A patent/EP1681074B1/en not_active Expired - Lifetime
- 2001-12-13 DE DE60137803T patent/DE60137803D1/en not_active Expired - Lifetime
-
2003
- 2003-10-03 US US10/678,525 patent/US20040116868A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075108A (en) * | 1986-01-03 | 1991-12-24 | Consolidated Pharmaceuticals, Limited | Melphalan derivatives |
US5069662A (en) * | 1988-10-21 | 1991-12-03 | Delcath Systems, Inc. | Cancer treatment |
US6071263A (en) * | 1992-03-02 | 2000-06-06 | Kirkman; Thomas R. | Apparatus and method for retaining a catheter in a blood vessel in a fixed position |
US5304120A (en) * | 1992-07-01 | 1994-04-19 | Btx Inc. | Electroporation method and apparatus for insertion of drugs and genes into endothelial cells |
US5405919A (en) * | 1992-08-24 | 1995-04-11 | The United States Of America As Represented By The Secretary Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders |
US5403834A (en) * | 1992-12-07 | 1995-04-04 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US6508777B1 (en) * | 1998-05-08 | 2003-01-21 | Cardeon Corporation | Circulatory support system and method of use for isolated segmental perfusion |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100030102A1 (en) * | 2006-05-15 | 2010-02-04 | David Poston | Active Delivery and Flow Redirections: Novel Devices and Method of Delivery of Materials to Patients |
WO2008143740A2 (en) * | 2007-04-06 | 2008-11-27 | Transcardiac Therapeutics, Inc. | Methods and devices for endocardiac access |
WO2008143740A3 (en) * | 2007-04-06 | 2009-02-19 | Transcardiac Therapeutics Inc | Methods and devices for endocardiac access |
US20100331854A1 (en) * | 2008-01-07 | 2010-12-30 | Ilan Greenberg | Device and method for performing treatment in a pericardial space |
WO2009094522A1 (en) * | 2008-01-24 | 2009-07-30 | Cedars-Sinai Medical Center | Tulip-shaped balloon catheter and methods for pericardiocentesis and percutaneous pericardiotomy |
US20110098672A1 (en) * | 2008-01-24 | 2011-04-28 | Cedars-Sinai Medical Center | Balloon catheter and methods for pericardiocentesis and percutaneous pericardiotomy |
US8361016B2 (en) | 2008-01-24 | 2013-01-29 | Cedars-Sinai Medical Center | Balloon catheter and methods for pericardiocentesis and percutaneous pericardiotomy |
US20090287240A1 (en) * | 2008-05-16 | 2009-11-19 | Ken Yamatani | Medical instrument introduction device and method of introducing medical device |
US8038610B2 (en) * | 2008-05-16 | 2011-10-18 | Olympus Medical Systems Corp. | Medical instrument introduction device and method of introducing medical device |
US20120078167A1 (en) * | 2010-09-27 | 2012-03-29 | Baker Andrew T | Stoma Length Indicator Assembly and Positioning System |
US9125800B2 (en) * | 2010-09-27 | 2015-09-08 | Avent, Inc. | Stoma length indicator assembly and positioning system |
JP2021058642A (en) * | 2015-10-30 | 2021-04-15 | セレバスク,インコーポレイテッド | Systems and methods for treating hydrocephalus |
Also Published As
Publication number | Publication date |
---|---|
US6692458B2 (en) | 2004-02-17 |
ATE328634T1 (en) | 2006-06-15 |
DE60120480D1 (en) | 2006-07-20 |
AU2002231025A1 (en) | 2002-07-01 |
WO2002049702A2 (en) | 2002-06-27 |
EP1349605A2 (en) | 2003-10-08 |
WO2002049702A3 (en) | 2003-08-07 |
DE60120480T2 (en) | 2006-10-19 |
EP1349605B1 (en) | 2006-06-07 |
JP2005500864A (en) | 2005-01-13 |
DE60137803D1 (en) | 2009-04-09 |
US20030036726A1 (en) | 2003-02-20 |
JP4159357B2 (en) | 2008-10-01 |
EP1681074A1 (en) | 2006-07-19 |
EP1681074B1 (en) | 2009-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6692458B2 (en) | Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis | |
US6685672B1 (en) | Multi-balloon drug delivery catheter for angiogenesis | |
US7399294B2 (en) | Controlled depth injection device | |
US6319230B1 (en) | Lateral needle injection apparatus and method | |
US6322548B1 (en) | Delivery catheter system for heart chamber | |
US6723081B1 (en) | Catheter system for the delivery of a low volume liquid bolus | |
US6217554B1 (en) | Methods and apparatus for delivering substances into extravascular tissue | |
US7226440B2 (en) | Method and device for accessing a pericardial space | |
JP4774403B2 (en) | System and method for non-invasive implantation of bioactive substances | |
US6723082B1 (en) | Delivery catheter system for heart chamber | |
US20080045890A1 (en) | Methods and systems for ablating tissue | |
JP2002507458A (en) | System and method for delivering a drug to a selected location in the body | |
JP2010537680A (en) | Minimally invasive endovascular treatment device | |
WO1996017644A1 (en) | Cardioplegia catheter system | |
WO1999049926A2 (en) | Delivery of an angiogenic substance | |
JP2004329552A (en) | Liquid medicine administering catheter | |
EP1188417A2 (en) | Method and apparatus for delivery of therapeutic agents to the heart | |
WO2000029056A2 (en) | Coronary infusion catheter and intra-coronary drug administration methods | |
US20230381469A1 (en) | Drug delivery balloon catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |